Post on 22-Feb-2023
FOR SUPPLY OF DRUGS & DRESSINGS
(VALID FROM 14th October,2021to 31"t October, 20231
STR]CTLY FOR OFFICIAL USE
EMPLOYEES' STATE INSURANCE CORPORATIONROOM NO.312 & 314, HQRS. OFFICE, PANCHDEEP BHAWAN
C.I.G. ROAD, NEW DELHI- 110 OO2
DRUGS FOR RESPIRATORY SYSTEM
DRUGS FOR CARDIO-VASCULAR SYSTEM
DRUGS ACTING ON CENTRAL NERVOUS SYSTEM
ESICGENTRAL RATE CONTRACT NO. - 143(C)
2A2L-2023
ESICCENTRAL RATE CONTRACT NO. - 143(G)
FOR SUPPLY OF DRUGS & DRESSINGS
(VALID FROM 14th October,2021to 31"t October' 20231
2*2:"-2*23
PUBLISHED BY
DIREGTOR GENERAL
EMPLOYEES' STATE INSURANGE CORPORATION-ioon No.312 &314,HQRS. oFFlcE, PANcHDEEP BHAwAN
C.I.G. ROAD, NEW DELHI- 110 OO2
RYRAT MTESSYoISE PRRFS oUR GD
DRUGS FUS SYSTEM
DRUGS ACTI
STRICTLY FOR OFFICIAL USE
SYSTEM
Sno. Contents PageNo.
1. Fonararding letter along with terms &conditions for operation of Rate GontractNo. 142 (C).
t-x
2. List of Approved Pharmaceutical firms.
?,FtA R*- - a4/rrl
1-3
3 Address with Terms & Conditions of theEligible firms
1-17
4. lndex 1-8
5. Rate Schedule
=i,.) ) 1)O)A
1-50
.e=
STRICTLY FOR OFFICIAL U SE ONLY
offirrqffcrfurc('Ic Fi {tsqE dililq, qna wiFrgEMPLOYEES' STATE INSURANCE
CORPORATION(Ministry of Labour & Employment, Govt. oflndia)
ITqTdq/HEADQUARTERS'riq{q rr+q, S"qdd rn f, +{ ffi - r ro oozPanchdeep Bhasan,C.I.G' Matg,New Delhl-110002
www.esic.nic.in, 80 1 1-23234334,8 dmc-rdaresic nic.in
^4^W,#r*tHtdd
No.U-ZslLzlt42C-1 202t
From
The Director General,E.S.I. Corporation,
Panchdeep Bhawan,
C.I.G Road,
ToDirector (Medica
Dean,
Medical
Director, ESI
Sub r
Sir / Madam,
Please flnd
supply of drugs and
Validity of this i.e. w.e.f,
14.1O.2O21 to 31'10'20
Further, the following terms
Contract:-
operation of the Rate
1. ImmediatelY on receipt of this communication, the Chief Direct Demanding Officers
(Director/Addl. Director/J I Officer/Diredor
Medical) Delhi & Noida shal and the officers who
have been designated as ration of this
Rate Contract on his beha toa ntract ers. Contract holders
would entetain the suPPlY orders & related correspondences from the officers working as
DDOs only after the receiPt of such communication from the Chief DDOS.
RC
for
(
I
rl
Colleges & Hospitals,
PURCHASE OF DRUGS AND DRESSINGS
CORPORATION CENTRALISED RATE CONTRACT
FROM 14.10.2021 TO 31.10.2023 .
UNDER THE E.S.I.
NO. 143C EFFECTIVE
the Rate
ECI(
2 supply orders will be placed by Heads of ESI Scheme of various states/ Deans/ lt4edical
Superintendents, ESIC [vlodel Hospitals, who for the purpose of this Rate Contract, shall be
designated as chief Direct Demanding officer and will exercise the powers of Director
General, ESI Corporation in all matters connected with the execution of supplies and / or
wherever specifically provided in the terms & conditions of the Rate Contract' The Chief
Dlrect Demanding Officer can also designate any of his subordinate officer as Direct
Demanding Officer (DDO) to operate this Rate Contract.
All the supply orders shall be signed only by the officers who have been duly authorised
and included in the:.list of'DDos.-DDOs-.will send rynn4{.9py of the Purchase
order through email.followed, by speed post directly tothe firm' ',
':: ', . -..:1.
The Chief DDOs may bring to the notice of the undersigned the discrepancies (especially in
rate, packing, composition of the drug) if any observed by them'
J
4
5. The Chief DDOs shall monitor
to their execution of suPPlY
supply report along with th
6. The applicabilitY
of the Ra
ilsasun
holding flrms in regard
ated quaterly non-
nder this
rates.
Act or
t necessary
ithin 4-6 week
B
9
supply orders will be placed from time to time during the currenry of the contract in which
tt-ili.a qrirtities required on each occasion together with the date. of delivery shall be
specifiedbytheDirectDernandin$.officers..,..i.....l'l
No guarantee can be given..as io the.,minimim quantiry frntir iritt be.di'awn against thls
.ont"ru.t but the pharmaceutical firm will supply quantity as may be ordered by the Dlrect
Demanding Officers during the currenry of the contract
l0.supplyordersagainstthecontractwillbeacceptedaslongasthesereachthepharmaceutical firm on or before last date of the currency of the contract' Supply orders
received during the closing days should be complied within due course, in accordance wlth
the contract iieven thoug'h in some cases owing to contract having expired, supplies are
to be complied with even;fter the expiry of the last date of the contract'
Qty. notsupplied
R.C.
No.
Item No. &Name of
Drug
7.
l
51 2
II
7. It will be ensured beford'placing ordqr. by the
funds are available and PaYment be arranged
time of the execution of the orders bry.the Rate
unnecessary delay in the payment of their bil!5: 'Contract Holder and there should not be
RemarksPaymentif
pending
RiskPurchase/
penaltylevied
withDate
Name of S.O..:No;
firm
8.6.3.
11. Notwithstanding any omission or shortcoming in the supply order it is incumbent upon the
Pharmaceutical firm to supply the item as per the specifications of the relevant rate
contract.
SUPPLIES
12. The purchaser will not pay separately for transit insurance and the contractor will be
responsible for delivery of items covered by the supply order in good condition at the
specified destination and for this purpose freight, insurance, Octroi etc, if any, will have to
be borne by the supplier. {he consignee'will, as-soon as po:qible, but.iiot later:than 30
days of the date oi arrival of stores at destination, notify the contractor of any loss or
damage to the storei,,that ma, lilve occurred ilu.ring thertr.anSiL ''.'..,.,' '... ,''
b) Loose supplies/damaged packing/tempered or damaged labeled supplies shall not be
accepted under any cireumstancest''a
c) Supplies to be made in, propeir boxes' . -i. - l
d) Liquid orals to be supplied only in glass/ plastic bottles conforming to Drugs &
Cosmetics Act and rules made there under.
e) Large volume parenterals to be quoted and supplied only in plastic bottles / polypacks- conforming to Drugs & Cosmetics Act and rules made there under'
III
shall beAct,
drug must2009 and
13. During transit pharmaceutical firm should maintain the recommended
temperature of the drug (wherever indicated), otherwise if on checking it is
found that temperature has not be€n mairitaind, supply,?gainst the said order
is liable to be rejected and cancelled. It will ber"counted as t non-supply.
14. The prices approved are FIO,R. Destination per unit and are exclusive of GST except
where indicated but inclusive of.all charges for packing and forwarding.
15. In all contracts for items/ drugs, which are branded with 'ESI SUPPLY' mark including
rejected items/ drugs, it would be a condition that such items/ drugs will not be sold to the
public/open market.
16. Marking:
Each packing shall be printed with nomenclature of the
labelled in accordance with the1940 and the rriles iiiade theie under.
comply with the procedure provided under the Legal
Drugs
rules made there under.
17. Packing:a) rt s[ould be ensured that all labelg-,of cartons, ampoules,'vialg bottles, jars,
tubes, tins, containers etc.i. have "For ESI rypply, Not to be sold"
imprinted/rubber stamping with indelible irlk clearly. Any consignment
wiihout such stamping will not be considered valid and will be rejected.
fl It should be ensured that only firct use packaging materia! of uniform size
including Bottles and vials should be used for making supplies on the basis of ESI
Rate Contract.
g) All primary packing containers should be strictly conforming to the specifications
described/ mentioned in the relevant pharmacopoeia.
h) Packing should be able to prevent damage or deterioration during transit.
i) All containers i . ei, bottles,.tins; carto$g tubes etc', are required tor-be secur€d with
pilfer-proof sealito ensurergenuinenels of the products packed and the corredness of
the contents. MRP should not be written on any labels othdriiVise,.itwill disqualified.
b)
c)
19.
Act.
20. The Stores accePted sh
1940 and the Rules m
Order.
mentioned against each
srons of Drug and Cosmetics
ould comply
ade thereunWithtiiir a
the provisions of-the Drugs ?nd Cosmetics Act,
s amended llpto latb and Drug Price Control
21. It should be ensured that IsI code No, is indicated on the packing and at the time of
supplies, it must be ensured that the items supplied has ISI Mark as well as code No.,
as ls the statutory requirement of the Bureau of Indian standards'
IV
18. Life Period :
.) For Drugs having shelf life of Two years or less: As on the date of delivery,
Drugs should noi be older than one fourth (1/a) of its shelf life from the date of
manufacture.
For Drugs having shelf life more than Two years: As on the date of delivery,
Drugs s[ould noi be older than one sixth (U6) of its shelf life from the date of
manufacture.
Imported Drugs: As on the date of delivery, Drugs should have a minimum
500/o of valid shelf life from the date of manufacture.
rm!
sEores a
22, Testino of Drugs - Oualitv Control
a. Approved Rate contract Holder should submit a Test Repoft that particular
bitch of medicines tested by the Governmenv Government approved
Laboratories (as per list circulated from ESIC Hqrs/ Hospitals/ state Govt. from
time to time) along with each supply.
b. The Director General, ESI Corporation shall be at liberty to undeftake regular
at the time of suoPlv
t
I If any drugs supplied against this Rate Contract are
standard quility on inspection by Competent Authority, th
will be liable to replace the entire quantity within 15
purchase will be charged from the,Pharmaceutieal firmt
If the product is found t6 be.'not'.of standdid. quality','the
recovered from the suPPlier.
If standard quality is not maintained in h'l'o batches in two years
duration of the rate contract, the drug of the that company will be
ur""[ri"t a and debarred from running in Esrc rate gg!tE!g!-&u!
oeriod of three vears.
found to be not of
e pharmaceutical firm
days othenarise risk
.1,
cost of testing will beh
and random testing of the drugs supplied by the pharmaceutical
regular interval.to maintain and ensure the aUllitY of'drugs.r
d.
c. The Chief D.D.OS may get at least l0o/o of the drugs tested
Laboratory, or in anY of the Govt. Approved laboratories' Instructions issued in
this regard from Hqrs. Offlce time to time.may please be adhered to'
Details of the items found not of standard quality should be brought to the
notice of the undersigned along with the test reports immedia!-'ly. All such test
reports should necesaarily come through Chief D'D.Os only. A'topy of the..test
report shou!(,be sent immadiately !o the firm, the'cbncerl9! Drug controllers,
and respectiVe Central Drug. Contrrjl authorities for necesaary''actloni'
23
bv ESIC for each categorv of defects, described as under:-
be initiated by the DDO's wherever payment had been made alrea(y, ..
Forfeiture offefoifr'ance Securiffim the respeitive,DGESICRqIe €ontract for all
the quoted drugs.
Debarring of tire Rate'contiact holdei / Pharmaieutical- firiir from current and all
Iries
II. If
a
pharmaceutical firm is
Recall of the NSQ item imm ta
CateggryBwithinaYearESIS User Units. Recoveries
to be initiated by the DDO's wherever payment had been made already'
. Fofeiture of Performance security from the respective DGESIC Rate Contract
for all the quoted drugs'
o Rate Contract Holdef Pharmaceutital firm will 6e {ebarred fidr further supply of
the said NSQ item in the currency of the Rate contract'
. Debarring of Rate contract Holder/ Pharmaceutical firm immediately from
current and all future DGESIC Rate Contracts for a period of three years'
. Rate Contract Holder/ Pharmaceutical firm will be liable to pay damages/
compensation(ifany)toindividual/individualsarisingduetoconsumptionofitem declared NSQ and in case of any adverse reaction reported in the Hospltal
during administration of the drugs.
VI
A. CATEGORY'A'DEFECT (Spurious / Adulterated Drugs)-
If any item / Batch of the item declared Not of Standard qualiU (NSQ) under
Category A .. Recall of the NSQ item immediately from all ESIC/ ESIS User Units. Recoveries to
future DGESIC Rate Contract for a period of five (5) years.
. Rate Contract Holder/ Pharmaceutical firm will be llable to pay damages/
compensation (if any) to individual/ individuals arising due to consumption of item
declared NSQ and in case of any adverse reaction repoted in the Hospital during
administration of the drug.
B, CATEGORY'B' DEFECT (Grossly Substandard Drugs)
C CATEGORY' C' DEFECT (Minor Defects)
I. If single item/ Batch of item is declared NSQ under Category C
. Recall of the NSQ item immediately from all ESIC/ ESIS User Units. Recoveries
to be initiated by the DDO's wherever payment had been made already.
. Forfeiture of Performance Security from the respective DGESIC Rate Contract
for that drug.
. Rate Contract Holder/ Pharmaceutical flrm will be debarred for futher supply of
the said NSQ item in the currency of the Rate-contract. ..-,,- .r .:-.,.
o Rate Contract Holder/ Pharmaceutical firm Will -be liable to pay damages/
compensation (if any) to individuali individuals arising due to consumption of
item declared NSQ and in case of any adverse reaction repod€jd in the'Hospital
during administration of the drugs.
u. If more than one item ing to any individual
pharmaceutical firm i NSQ u C within a year
Recall of the N nits. Recoveries
to be in already.
Fofeitu Security Rate. Contract
for all the rugs.
supply of
from
ages/
of
ospital
a. Delivery of si
by email a in stipulated
time.
b. If the pharmaceutical firm e supply order within the
stipulated period of six weeks, a penalty of two (2) per cent of the va lue of
the order catculated at the contract rate per week or a part of a week wi ll be
levied. The maximum 10% of the
total extension of
the d ding Officers,
if itpermissible for a maximum period of 5 week only but penalty will be levied.
a
24.
VII
weeks from of the P.O. sent
for late
a extension isituI
In case of failure to supply, the Corporation reserues the right to purchase
the stocks from other sources as risk purchase, i.e' purchase from any other
pharmaceutical firm or firms, in the rate contract or from outside the contract
at the discretlon of the Direct Demanding Officer concerned at a competitive
rate or from local chemist.
That extension of deliverv oeriod cannot be claimd as a malter ofrioht but will be at the discretion of con@med cttricen
If the iterns/ drugs
or by the ,extendednot suppiieii is I
ot suppli
) full o1to be
d (as i
the sk
ect
an
ndicated above
of,lhe quantity
d expense of
d are n'date
iable
e
25. Quoting
a.
pharmaceutical firm. The extra expenditure involved in procuring supplies
from elsewhere i.e. Local Pu rm/other running Govt. Contract etc',
in that case, will be utical firm, in full atthus due will be
Officer or which ator any other
He will be
tion in
n, the
bidd deposit invite
other from Rate
reentrynextgof
edule
rges.
b. GST, if extra, where legally leviable and intended to be claimed, should be
distinctly shown separately alongwith the price qu.oted.. where this is not done,
no cfaim of GST will''be aamtea at anyt tatAi stdile 6iiQ on any ground
whatsoever,
\NII
c.
L'
26. Pavment
27.
30.
31.
32
Payment for the supply will be made within 4 to 5 weeks (after receipt and
aiieptance of the diugs/items) directly by the Direct.Demanding Officers or
through nominees to w6om bills are submitted. Notwithstanding any omission or
in"riC'o.i.g in the supply order it is incumbent upon the pharmaceutical
fii./UtOaeito supply the items as per the specifications of the relevant rate
coniract. No claim ior the payment from contractor shall be entertained after the
lapse of three years of arising of the claim.
Any dues or payments that have arisen to the Corporation from the
pharmaceuticalfirmforwhichnospecifictimelimithasbeenlaiddowninthe
terms and conditions shall be payable by the pharmaceutical firm within such time
limitasmaybeprescribedintheletters/ordersaddressedtothepharmaceutical
firms.
Any payments that have been demanded as per the provisions of above
mentionedclauseorunderanyotherclauseshallbepayablewithinthetimelaiddown. On failure to do so: -
. The pharmaceutical firm shall be liable to be debarred for supplying items/
drugi etc. to the Corporation for a period not exceeding three years'
. The Corporation reserves its right to take appropriate legal action against.the
;;f;rlti;g fiils as may be le{ally advised, including claim for compensation
unJaurig.t for the period oldelay and / or simple interest 10o/o per annum
for each daY of default'
RateSchedulealongwithlistofitem.wisefinalizedrates,alongwith.nameofthe;;;;";;; nrr* is ericlosed. In regard to items where rates of more than one firm
nll. U... .pptoved, order shouli be placed to the firm at First Preference and
whose rates are the lowest. In case oi non-supply by such firm, order shall be
pf.i.J t" tn" firm with the next higher approved rate invoking risk purchase'
No other document should be entertained for giving any cognizance for placing the
supply orders.
Acceptance letter issued to the firms by this office cannot be used for placing
orders.
it"t!N, under Ministry of Labour'& employniEnt has granted exemption .to
operaie'OCSfC Rate Contract for drugs and dressings as per Minutes o-F^the
nieeting vide office Memorandum no. z-i0025 l25l2ol7-Adm II dated 29.01.2021.
IX
28,
29.
33
34 It shall
Encl.: As above.
All Chief Di
information
all DDOs u
send the list
PPS/PS to Di
PPS/PS to Fi
PPS/PS to Medical
Medical Administration
Accounts Branch -V (Hq
has come to an end or ceased to exist.
Force Majeure:- -if rf .ny time during the applicability of Contract the bidder fails to discharge its
OUfiguiion due to f6rce maieure (natural disaster. or act of God etc') he will
p.,ipuv notify the Director'General or its representative about the happening of
iuctr'an eveni. The Director General or its representative is solely engtlqd to
i"*init"l determine the order/contract in respect of such performance of .the-
UiaO"rirl'oUfigutlons if he so desires. The obligations under the contract on behalf
of biddei for the contract shall be resumed as soon as practicable after the event
Indruglevel with strict control as per ABC-VED matrix and
formutary of the respective institution is followed in right earnest to
provide medical services to
This issue with the a
ity of of
s foron9
to
I Education /
Copy tor
1
2
3
4
5
Dv. Medical Commissioner (RC)
Forr DTRECTOR GENERAL
202L-2023
x
Yours faithfullY,
/<Dy. Medical Commissioner(RC)
FOT: DIRECTOR GENERAL
Approved Vendor List 143C
Name of the FirmSNo,
Abbott India Limited1
Healthcare Limited2
Baxalta Bioscience India Private Limited3
Baxter4
m5 Bharat
heim India PrivateInBoeh6
7
8 LimitedCi
P9
Emcure10
FDC Li11
tz
13
Habt4
Hindustan15
Intas16
ofluggat Pharma
Pharma D leI77
Lark Laboratories ndia18
Macleods Pharma19
Ltd20
Mesmer Pharmaceuticals2L
Micron Pharmaceuticals22
Page 1of 3
Ltd
Ltd.
'l
Approved Vendor List 143C
Name of the FirmSNo.
re Pharmaceuticals ht. Ltd.Midas G23
Prlvate LimitedModi Mund24
Overseas Healthcare h/t Ltd25
26 Pfizer Lim
Pfizer Prod27
AA LtdPrecise Chemi28
India29
Pulse30
31 Revat La
Roche32
iPa33
Sanofi -34
Sanofi I35
Serdia36
37
Sun Pharma La38
LimitedTablets39
Themis Medicare Limited40
Troikaa Pha47r
USV Private Lim42
Virchow Biotech h/t. Ltd43
Wallace Pha rmaceutica ls h/t. Ltd.44
Windlas Biotech Private Limited45
h . Ltd.Zenith46
Page 2 of 3
*
tatt
)rar(
(aIl
rs*t Kffi r43{c}
Approved Vendor List 143C
Name of the FirmSNo,
47 Zim Laboratories Limited
48 Zuventus Healthcare Limited
care LtdS49
Page 3 of 3
vendor NameABBOTT INDIA LIMITED
3 Corporate Par( Sion Trombay
Road, Chembur Mumbai 400071
Mobile/ Tel No:9987072315 /(91-22) 38160s27
Fax No (if any): (9
Email: institution.busin
1-22) 38162401
ess@abbott.com
II,.
s63 I
Vendor NameBA]AJ HEALTHCARE LI
602-606, 6th Floor,
Infotech Park, Plot
No. 23, Above IIndustrial Estate,
Mobile/ Tel022-66t77400
Fax No (if any):Email:
Vendor NameBAXALTA BIOSCIENCE IPvT. LTD
6th Floor, Building no. 8, Tower C,
DLF Cyber City, DLF Phase
Gurgaon 122002 Haryana
Mobile/ Tel No: 8448815
0124-4559100
Fax No (if any): 0125-4559109
Emailt tenders.india@takeda.com
Term 1 Delivery within 6(six) weeks (of the actual date
of dispatch) of supply order on FOR Destinatlon
basis
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
Term 3 If at any time documents submitted/information given by the flrm in the tender is
found to be false/ erroneous, the award will be
cancelled.
'Teim 4 Supply to be made direcUy.
weeks (of the actual date
er on FOR Destination
where no
except for items
submitted/tender is
will be
lirectly.
order on FOR Destination
(of the actual date
Term 2
Term 3
GST as applicable will be extra except for items
documents submitted/the firm in the tender is
found to be false/ erroneous, the award will be
cancelled.
n s
approved.
Term 4 Supply to be made directly.
Page 1 of 17
Term 1
Term 2
'Term 3
Term 4
Term 1
where
Vendor NameBAXTER INDIA PRIVATE
LIMITED
5th Floor, Tower-A, Building No. 9,
DLF Cyber City, DLF Phase III,Gurgaon-122002, Haryana
Mobile/ Tel No:9810592367 /0Lz4-4200200
Fax No (if any): 0tZ4-+20020
Email: rahul-gupta@baxter.com
baxsolutions India@baxter.com
Vendor NameBHARAT SERUMS AND
VACCINES LIMITED
3rd Floor, Liberty Tower, Behind
Reliable Plaza, Airoli, Navi Mumbai -
400708
Mobile/ Tel No: 9910025803 /022-45043476
Fax No (if any): 022-45043200
Email:vishwadeep,srivastava@bharatserums.com
sandeep.shinde@bharatserums.com
institution@bharatserums.com
sunny,bhardwaj@bharatserums.c0m
Vendor NameBOEHRINGER INGELHEIMINDIA PRIVATE LTD
1102, 11th Floor, Hallmark Business
Plaza, Gurunanak Hospital Road,
Near Gurunanak Hospital, Bandra -,,.,':..
East, Mumbai, India - a0005,f..,
Mobile/ Tel No: 9311210727 /9t-22-264564779t-22-7t456477Fax No (if any): 9I-22-71456766Email: ratan.sharma@boehringer-
ingelheim.com
Pmibtender.in@boehringer-ingelheim.com
Delivery within 6(six) week (of the actual date
of dispatch) of supply order on FOR Destination
basis
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
Term 3 If at any time documents submitted/information given by the firm in the tender is
found to be-false/,erroneous, the award will be
cancelled.
Term 4 Supply to be made direcdy.
Term 1
Term 2 GST as applicable will be eara except for items
where no tax has been approved.
Term 3 If at any timeinformation given by
documents submitted/the firm in the tender is
found to be false/ erroneous, the award will be
cancelled.
Term 4 Supply to be directly.
Term I Delivery within 6(six) weeks (of the actual date
of dispatch)-of supply order on FOR Destination
basis
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
.Terrh 3 : tirne.'.. documents su
information given by the firm in the tender is
found to be false/ erroneous, the award will be
If at .. ahy bmitted/
cancelled
Term 4 Supply to be made directlY.
Term 1
Delivery within 6(six) weeks (of the actual date
of dispatch) of supply order on FOR Destination
basis
made
Page 2 of L7
Vendor NameCENTAU R PHARMACEUTICALS
PvT. LTD.
Centaur House, Shanti Nagar,
Vakola, Santacruz East, Mumbai -
400055.
Mobile/ Tel No:' 9820244293 I02266499270 /0
Fax No (if any):Email: institutions@
IC.com
sameer@centaurlab.com
Vendor NameCIPLA LIMITED
Cipla House Pen
ParK Ganpatrao
Parel, Mumbai-
Mobile/ Tel N8874450173 I022 24826000
Fax No (if any)Emaillmanish.s@Cipla.com
Vishwas.Ahuja@Cipla
Vendor NameConcept PharmaceuticalsLimited
801, Hubtown Solaris (entrance
From B Wing) N S Phadke Miirg, OffTeli Galli, Near Andheri Flyover,
Andheri (East), Mumbai-400069
Mobile/ Tel No: 9891249600 /022- 42418888
Fax No (if any): 022- 42418888
Email: saniay.vasudeva@yahoo.com
concept.pharmaltd@gmail.com
Term 1 Delivery within 6(six) week (of the actual dateof dispatch) of supply order on FOR Destination
basis
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
Term 3 If at any time documents submitted/information given by the firm in the tender is
..founQjo be false/ erronequs, the award will be
cancblled.iTerniS Supply- to be made directy.
/eeks (of the actual daterrder on FOR Destination
for itemsr except'ed.
tender is
rd will be
submitted/
weeks (of the actual date
order on FOR Destination
s
su pply
Term 2
11"
GST as applicable will be extra except for items
where notax has been approved.
Term 3 If at any time documents submitted/
information given by the flrm in the tender is
found to be false/ erroneous, the award will be
cancelled.
Term 4 Supply to be made directly.
Page 3 of 17
Term 1
Term 2 GST
,.Term 3
Term 4
Term 1
Vendor NameEMCURE PHARMACEUTICALSLIMITED
Survey No. 255/2, Phase I, Rajiv
Gandhi IT Park, MIDC, Hinjawadi,Pune - 411057
Mobile/ Tel No:9830890292 174020 39821000
Fax No (if any):Email: nitind@emcure.co.in
niladri.das@emcure.co,in
anil.arora@emcure,in
Vendor NameFDC LIMITED
142-48, S.V.
(West) 400102
9970009897 /9830890292,7 4287 74333 I 020 39821000
Fax No (if any): 020 39821020
Email: anil.arora@emcure.in
nitind@emcure.co.in
satyajit.paul@emcure.co.in
9370130077,
287t433j
020 39821020
Survey No. 255/2, Phase I, Rajiv
Gandhi IT Park, lvlIDC, Hinjawadi,
Pune - 411057
Mobile/ Tel No: 9370130072,
Term 1 Delivery within 6(six) week (of the actual dateof dispatch) of supply order on FOR Destinationbasis
Term 2 GST as applicable will be extra except for itemswhere no tax has been approved.
Term 3 If at any time documents submitted/n the tender is
award will be
Terrh 4-
ks (of the actual date
3r on FOR Destination
xcept for items
L
submitted/e tender is
rd will be
ctly.
order on FOR Destination
(of the actual date
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
If .-tatr: any .rtime documents submitted/information given-by the firm in the tender is
found to be false/ erroneous/ the award will be
cancelled.
Term 4 Supply to be made directly,
Page 4 of L7
Mobile/ Tel No: 8652684108
I 8554925907 97-22 267 3937 7
Fax No (if any): 022-26773462
Email: tenders@fdcindia.com
Vendor NameGennova Biopharmaceticals Ltd
SupDli to be re(
1Term
Term 2
3Term
Term 4
Term 1
Terii,r 3
Vendor NameGOPAL DAS VISRAM ANDCOMPALNY LIMITED
8, Fida Building, 18 Shamaldas
Gandhi Marg, Dawa Bazar, Mumbai :
400002
Mobile/ Tel No: 98
022-2240t7281 99
Fax No (if any):Email: taxationdept2ol6@gmail.com
Vendor NameHAB
RESEARCH LTD
Fax No (if any):Email: marketing@
Vendor NameHINDUSTAN LABORATORIES
LIMITED
Mobile/ Tel No:7710055194 /98207 87 s58 I 02242460500,42460526
Fax No (ifany): 022-42460531
Email: tender@hindlab.com
kunjaldedhia@hindlab,com
A-302, Victory Park, Chandavarkar
Road, Borivall (West), lYumbai -
400092, Maharahstra
C
Term 1 Delivery within 6(six) weeks (of the actual dateof dispatch) of supply order on FOR Destination
basis
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
Term 3 If at any time documents submitted/n n the tender is
award will be
ca
Term 4 Supplfto be mate directli.'
(of the actual date
on FOR Destination
pt for items
wheft
erm 3 anyIf at submitted/tender is
rd will be
order on FOR Destination
(of the actual date
GSI as.applicable.Will be extra except for ite
where no tax has bedn approved.
ms
Term 3 documents submitted/
information given by the firm in the tender is
found to be false/ erroneous, the award will be
cancelled.
Ifata
Term 4 Supply to be made directly.
Page 5 of 17
308 3rd Floor T.v Industrial Estate
S. K Ahire Marg Worli Mumbai 30
Mobile/ Tel No: 9930212908 /022-66267409
Term 1
Term 2
Term 4 Supply to be made directly.
Term 1
2tTgrm
Vendor NameINTAS PHARMACEUTICALS
LIMITED
Corporate House, Near Sola Bridge,
S.G. Highway, Thaltej, Ahmedabad-
380054
Fax No (if any):Email: ketan_shah@intaspharma.com
Vendor NameJuggat PharmaDivision ofPrivate Limited)
No.782, 15th
J.P.Nagar,
Bangalore - 560
Mobile/ Tel No26635026,
Fax No (if any):Email:tenders@jagdale.com
Vendor NameLARK LABORATORIES (INDIA)LTD.
Mobile/ Tel No:079-39837000
932802s602 I
A-105 12, Okhla Industrial
Phase-Il. New Delhi-110020
Fax No (if any): 9l-7492-225137Email: tender@larklab.com
larklab@gmail.com
Term 1 Delivery within 6(six) week (of the actual date
of dispatch) of supply order on FOR Destination
basis
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
Term 3 If at any time documents submitted/n the tender is
award will be
Term 4 Supply to be made dirbctly.
(of the actual date
FOR Destination
award will be
submitted/tender is
Delivery within 6(six) week (of the actual date
of dispatch) of supply order on FOR Destination
basis
Term 1
Term 2 GSf;arppiicable wiil be extra except for items
where no tax has been
Term 3 If at any time documents submitted/
information given by the firm in the tender is
found to be false/ erroneous, the award will be
cancelled.
Term 4 Supply to be made directly.
Page 5 of 17
Mobile/ Tel No:9811023731 /0tt-407L7777
Term 1
GST as applicable will be extra except for items
where no tax has been approved,Term 2
If at any time
information given by
found to be false/ erroneous/
cancelled,
Term 3
Term 4 Supply to be made directly.
oo(
Vendor NameMACLEODS PHARMACEUTICALS
LIMITED
Atlanta Arcade, Marol Church Road,
Opposite Leela Hotel , Andheri
(East), Mumbai - 400059
Mobile/ Tel No: 8
98678680021 022
Fax No (if any): 0
Email: tendem@macleodspharma.com
oshukla@macleodspharma,com
Vendor NameMEDLEY
LTD
Add - Medley ho
Andheri (E), Mu
Vendor Name
MESMER PHARMACEUTICALS
Vedha No 13, Mangala N
Main Road, Porur, Chennai-
600116,Tamil Nadu.
Mobile/ Tel No: 9444903427 I044-22522678
Fax No (if any): 044-22522592
Email: gvsmani.mesmer@iconlife.in
tenders.mesmer@iconlife,in
Term 1 Delivery within 6(six) week (of the actual date
of dispatch) of supply order on FOR Destinationbasis
Term 2 GST as applicable will be extra except for items
where no tax has been approved,
Term 3 If at any time documents submitted/the tender is
award will be
(of the actual date
FOR Destination
for itemsTerm 2 G.ST as applrcwhere no tax h
Term 3
rd will be
submitted/e tender is
Delivery within 6(six) weeks (of the actual date
of dispatch) of supply order on FOR Destination
basis
::Term 2 GsTiatappliciiUlel^iill be extra except for items
w.lerelo91nas b€qt approved.
If at any time documents submitted/information given by the firm in the tender is
found to be false/ erroneous, the award will be
cancelled.
Term 3
Term 4 Supply to be made directly.
I
Mobile/ Tel Not 93222M643 I982103 1003/022 687 57 57 5
Fax No (if any): 02228204453
Email : tdkkrishna@gmiil.com
arshad.jafferey@medleylab.com
Term 4 Supply to be made directly.
Term I
Term 4 Supply to be made directly.
Page 7 of 17
Vendor NameMICRON PHARMACEUTICALS
Plot no 2117 A-2 Phase III GIDC
Vapi 396 195
Mobile/ Tel Nor 9924170750 /9820081388/ 0260 74054001
0s106107
Fax No (if any): 0260 2405479Email: contactus@micronpharma.ln
sales@m icronpharma.in
vendor NameMIDAS CARE
PHARMACEUTICALS PvT. LTD
Lotus Corporate Par( B Wng, 3rd
Floor, Jay Coach, Graham Firth
Compound, WE Highway, Goregaon
(East), Mumbai 400063
Mobile/ Tel No:9867478316 /022-42193900
Fax No (if any):Email: nandan@midas-cire.com
tender@midas-care.com
Vendor NameMODI MUNDIPTIARMA PRIVATELIMITED
1400, MODI TOWER, 98, NEHRU
PLACE, NEW DELHI-110019
Mobile/ Tel No:9810203582 /011-4250 4555, 011 4250 4992
Term 1 Delivery within 6(six) week (of the actual date
of dispatch) of supply order on FOR Destination
basis
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
Term 1 Delivery within 6(six) weeks (of the actual date
of dispatch) of supply order on FOR Destination
basis
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
Term 3 If at any time documents submitted/information given by the firm in the tender is
found to be false/ erroneous, the award will be
cancelled.
Supply to be made directly.
Term 1 Delivery within 6(six) weeks (of the actual date
of dispatch) of supply order on FOR Destination
basis
Term 2 GST' as applicable will be extra except for items
where no tax has b€en approved.
Term 3 If at any time documents submitted/information given by the firm in the tender is
found to be false/ erroneous, the award will be
cancelled.
Term 4
Page 8 of 17
,
Fax No (if any): 011-2645 1659
Email: pmd@modimundipharma.com
arvindmadan@modimundipharma,com
Term 3 If at any time documents submitted/information given by the firm in the tender is
found to be false/ erroneous, the award will be
cancelled.
Term 4 Supply to be made direct]y.
Term 4
l.l ,lrI'\ar-t
Supply to be made directly.
Vendor NameOVERSEAS HEALTH CARE PvT.LTD.
335Km Milestone, National Highway
No.1, P.O. Box 25, Phillaur, District
Jalandhar, Punjab State
Mobile/ Tel No: 9872019733 /07826-222886
Fax No (if any): 07826-222885
Email: info@overseasheil$rcarri.io.in
dmohcpl@gmail.com
Vendor NamePFIZER LIMITED
The Capital 1802/
70, G-Block, Ba
Bandra (E) Mum
Mobile/ Tel97714t47561
Fax No (if any)Email:
Rajesh.kadian2@pfizer
Satendra.seth@pfizer
Vendor NamePFIZER PROCUCTS INDIA PVT
LTD
The Capital 1802/1901, Plot No. C-
70, G-Bloc( Bandra Kurla Complex,
Bandra (E) Mumbai - 400051
Mobile/ Tel No: 9771414156 i2266932000
Fax No (if any): 2226540274
Email:GOVERNN4ENTTENDERSPPIPL@pf izeT,com
Rajesh.kadian2@pfizer.com
Satendra.seth@pf izer,com
Term 1 Delivery within 6(six) week (of the actual date
of dispatch) of supply order on FOR Destination
basis
Term 2 GST as applicable will be extra except for items
where no tax has been approved,
Term 3 If at any time documents submitted/
information given by the firm in the tender is
,found.to be felse/ erroneo-us, the award will be
cancelled. ' i'Ter.!:nt Supply'to be made directly.
eeks (of the actual date
rder on FOR Destination
for itemsr exceptred.
submitted/tender is
will be
Ddlivery within 6(six) week (of the actual date
of dispatch) of supply order on FOR Destination
basis
for itemsaar.T 7
Term 3 If at any time documents su
information given by the firm in the tender is
found to be false/ erroneous, the award will be
bmitted/
cancelled.
Supply to be made directly.Term 4
Page 9 of 17
Term 1
Term 2
3Term
4
found to be false/
Term L
approved,
Vendor NamePRECISE CHEMIPHARMAPvT.LTD
Offlce No. D-4, Neelkanth Business
Park, Nathani Road, Vidyavihar(West), Mumbai - 400 086
Mobile/ Tel No: 98191-49266 /91-22-68783333 ., t,
Fax No (if any): 91-22tir83333Email : tenders@precisegroup.co.in
Vendor Name -.:.
PSYCHOTROPICS II{DIIA]LIMITED
Plot No. 17, Sector- 20 A,
Faridabad-121001
0t29-228269t
Fax No (if any): 0L?9-2296764
Email: kapoorsatishT2@yahoo.com
Vendor Name r',t;
PULSE PHARMACEUTICAT PVT
LTD
Plot No: 18/1, Sector III, HUDA
Techno Enclave, Hitech City,
Hyderabad - 500 081.
Mobile/ Tel No: 9346155755,
9311083087 /97-40-23t79992Fax No (if any): 91-40-23119992
Email: suresh@pulsepharma.net
dineshkumar@pulsepharma.net
Term 1 Delivery within 6(six) weeks (of the actual date
of dispatch) of supply order on FOR Destination
basis
GST as applicable will be extra except for items
where no tax has been approved.
Term 3 If at any time documents submitted/information.given ,by the fffn jn the tender is
found to bdftlse/ brrdnq0us, tlie award will be
cancelled.
Terit 4' pply to be made directly.'Su
livery within 6(six) weekof dispatch) of supply order on FOR Destination
(of the actual date
basis
Term I
Term 2 G pt for items
Te rm3 If at any time documents submitted/
information given by the firm in the tender is
found to be false/ erroneous, the award will be
cancelled,
Supply to be made direcUy.Term 4
Term 1 6(six) week (of the actual date
supply order on FOR Destination
basis
G,ST as applicable will be extra except for items
where.no tax has been approved.
documents submitted/
information given by the firm in the tender is
found to be false/ erroneous, the award will be
cancelled.
If at any ttme
Term 2
.: -
Term 3
Term 4 Supply to be made direcfly.
Term 2
Page 10 of 17
Vendor NameREVAT I.ABORATORIES PvT.LTD,
8-2-700, Srida Anushka Pride , Road
No.12, Banjara Hills, Hyderabad -
500 034
Mobile/ Tel No:040-23097936
98q5t215ss /.-.,:'.
Fax No (if any): 0091-040-
23095071
Email: anilminol23@gmail.com
Mobile/ Tel97 22 50457300
Fax No (if any): 9
Email: nernelin
rajenderan.krishnamu
Vendor NameSAI PARENTERALS PvT LTD
Fax No (if any): 0091-040-
23095071
Email: md.saiparenterals@gmail.com
saiparenterals@gmail.com
8-2-700, Srida Anushka Pride , Road
No.12, Banjara Hills, Hyderabad -
500 034
Mobile/ Tel No:9885021555 /040-23097936/9848237 737
Term 1 Delivery within 6(six) week (of the actual dateof dispatch) of supply order on FOR Destination
basis
Term 2 GST as applicable will be extra except for items
where no tax has been approved,
,It:"submitted/
the tender is
award will be
f
ca
**,1 Supply to be made directly.
the actual date
R Destination
submitted/
award will be
Term 1 Delivery within 6(six) week (of the actual date
of dispatch) of supply order on FOR Destination
basis
. Term 2 GST aiapplicable'will be extra except for items
where no Ex has bd4r approved.
Term 3 If at any time documents submitted/information given by the firm in the tender is
found to be false/ erroneous, the award will be
cancelled.
Supply to be made directly.Term 4
Page 1l of 17
Vendor NameRoche Products (India) Pvt.Ltd.
146-8, 166 A, Unit No. 7,8,9,8thFloor, R City Office, R City Mall
Lal Bahadur Shastri Marg,Ghatkopar,
Mumbai - 400 086
Term 1
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
3Term
ths firm in the tender is
If at
candelled.
4Term Supp[l to be niade directly.
na,
Vendor NameSanofi - Synthelabo (India)Private Limited
Sanofi House, C.T.S No.117-B, L&T
Business Park, Saki Vihar Road,
Powai, Mumbai - 400 072
Mobile/ Tel No: 9312403063 /916790s0091 022
Fax No (if any): 02
EmaiI institution.busin
institution.business@sanofi.com
vendor NameSANOFI INDIA LI
Sanofi House, C.T.
T Business Parl!Powai, Mumbai -
Vendor NameSERDIAPHARMACEUTICAL(INDIA)PvT.LTD
1703, 17th Floor, Parinee Crescenzo,
'B' Wing, Plot Nos. C 38 & 39, 'G"Block, Behind MCA, Bandra Kuila .i'
Complex, Bandra (East), Mumbai -400051.
Mobile/ Tel No: 9449068957 /022 - 68100700
9
,com
Term 1 Delivery within 6(six) week (of the actual date
of dispatch) of supply order on FOR Destination
basis
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
Term 3 If at any time documents submitted/
information given by the firm in the tender is
.found to be false/ erroneous. the award will be
iancelled. ' 'Term 4 Supplv'to be made directly.
eeks (of the actual date
rder on FOR Destination
tra except
oved.for items
submitted/the tender is
award will be
order on FOR Destinationks (of the actual date
Term 2 GST as applicable will be extra except for items
wlidre no-tatrhe biieh approved,
If at any time documents submitted/
information given by the firm in the tender is
found to be false/ erroneous, the award will be
cancelled.
Term 3
Term 4 Supply to be made directly.
Page 12 of 17
Mobile/ Tel No:9312403063 /9167905009/ 022 28032000
Fax No (if any): 022 28032939
Email: institution.business@sanofi.com
institution.business@sanofi .com
Fax No (if any):Emai!: m.gurulingam@servier.com
serdia.sales@servier.com
0i20
1Term
Term 2
Term 3
cancelled.
Term 4 Supply to be made directly;
Term 1
Vendor NameSIGNATURE PHYTOCHEMICAL
INDUSTRIES
310, 3rd Floor T.V Industrial Estate
S.K Ahire Marg Worli Mumbai 30
Mobile/ Tel No: 9930212908 /022-66261400
Fax No (if any): 022-66241.41
Email : marketing@signaturepi.in
marketing@habpharma.in
Vendor NameSUN PHARMA LABORATORIES
LIMITED
Sun House, 201 B/1, Western
Express Highway, Goregaon East,
Mumbai - 400063
Mobile/ Tel No:9819319102 /022 4324 4324
Fax No (if any): 022 4324 4343
Email:hemantakumar,meher@sunpharma.com
Fax No (if any): 044 - 28589090
Email : hd@tabletsindia.com
Term 1 Delivery within 6(six) weeks (of the actual date
of dispatch) of supply order on FOR Destination
basis
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
If at any time documents submitted/information given by the firm in the tender is
found to be false/ erroneous, the award will be
cancelled.
Term 4 Supply to be made directly.
Term 1 Delivery n 6(six) weeks (of the actual date
of dis
basis
of supply order on FOR Destination
GST as applicable will be extra except for items
where no tax has been approved.
Term 3 if at any time documents submitted/
information given by the firm in the tender is
found to be false/ erroneous, the award will be
cancelled.
Term 4 Supply to be made direcdy.
Term I
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
Term 3 If at any time documents submitted/
information given by the firm in the tender is
found to be fulse/ erroneous, the award will be
cancelled.
Term 4 Supply to be made directly.
Page 13 of 17
\
J(
Vendor NameTABLETS (INDIA) LIMITED
# 72, Marshalls Road, "Jhaver
Centre" R A Building, 4th Floor,
Egmore, Chennai - 600 008 '
Mobile/ Tel No:9600152152 /0zl4 - 42050186
()
Term 3
r)l
Term 2
Delivery within 6(six) weeks (of the actual date
of dispatch) of supply order on FOR Destination
basis
t
lU 12,Udyog Naga r,S.V. Road,
Goregaon(W),M umbai-400 104
Mobile/ Tel No:9022951026 /91-22-67607080
Fax No (ifany): g!-22:'. , i6760707012874662t
Email: instmgr@ttremismedicare.com
Vendor NameTRIOKKA PHARMACEUTICALS
LIMITED
Commerce House-1, Satya Marg,
Bodakdev, Ahmedabad - 380054
Mobile/ Tel No:9879615617 /07 9 -268s6242 I 43 I 44 I 45
Fax No (if any): 079-26856246
Email: head-inst@troikaapharma.aom
tenderorder@troikaaphama.com
Vendor NameUSV PRIVATE TIMITED
Fax No (if any): 022 25584025
Email: manoj.sharma@usv.in
chhotelal.tiwari@usv.in
Delivery within 6(six) week (of the actual dateof dispatch) of supply order on FOR Destinationbasis
Term 2 GST as applicable will be extra except for itemswhere no tax has been approved.
Term 3 If at any time documents submitted/information given by the firm in the tender is
found to be false/ erroneous, the award will be...ca ncelled .
Term 4
1Term Delivery within
of dispatch) ofbasis
(of the actual date
on FOR Destination
Term 2 GST as applicable will be-e*ra except for items
where no tax has been approved.
Term 3 If at any time documents submitted/information given by the firm in the tender is
found to be false/ erroneous/ the award will be
cancelled.
4 Supply to be made directly.
ofispatch
kswee of het ctuaa datetxwith n 6 ) (ry (FOn DeR natisti nou rdero od p lyp
Term 2 GST as applicable will be extra except for items
nl.. !.,t9...
approved.Xtawh9.!'e
Teriir 3
found to be false/ erroneous, the award will be
cancelled.
If atiriform
ts
mti mdocu nts s bu ittedm
n n het rmfi n ht tender Sati ve by
Term 4 Supply to be made directly.
Page L4 of 17
Vendor NameTHEMIS MEDICARE LIMITED
Arvind Vitthal Gandhi Chowk, B.S.D
Marg, Govandi Station Road,
Mumbai - 400088
Mobile/ Tel No:9004084309 /987 159 49 46 I 022 255 64048
Term 1
Term 1
Plot No. 319 & 320, 3rd
FloorSwamyAyyappa Co-op. Housing
Society, Madhapur, Hyderabad 500
081
Mobile/ Tel Nor
8879110909/097000u€?0 /+91-40-23119481
+91-40-23119486
Fax No (if any): Fax No:
23119486.
Email: shambhu.s@virchowpharma.com
sham bhu.s@virchowpharma.com
Vendor NameWINDI.AS BIOTECH PRIVATE
LIMITED
7 05-706, Vatika Professional point,
sector-66 golf course ext, road,
Gurgaon-122001 Haryana
Mobile/ Tel No:9555823672 /t24-2821030
Term 1 Delivery within 6(six) weeks (of the actual date
of dispatch) of supply order on FOR Destination
basis
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
Term 3 If at any time documents submitted/
information given by the firm in the tender is
the award will beeolltel erbe.fals
nci:lled
.a,
ufo dn to ron
ca
Term 4 Supply to be made directly
actual datery withinDestinationdispatch) ofof
basis
'Term 1
pt for itemsterm z
ca
submitted/the tender is
award will be
.ate firm tnnformation g
thebe fa
mdocunatIhMen
tondfou se/
Term 3
Term 4
term I
basis
6(six dI ateks fo het cta uaWC) (
nDeR onatistirdero no FOUsd pp ly
Term 2 GST as applicable
where no tax has
be extra except for items
approved.
will
information given by the firm in the tender is
found to be false/ erroneous, the award will be
If at documents submitted/mea
cancelled
'-Term 3
Supply to be made directlY.Term 4
Page 15 of 17
Vendor NameVIRCHOW BIIOTECH PvT LTD
Vendor NameWALLACE PHARMACEUTICATS
PVT. LTD
A 303/312 Floral Deck Plaza; Off
Central MIDC Road, Andheri (East),
Mumbai-400093
Mobile/ Tel No:
9820360019i981112970t I022-68311100
Fax No (if any): 022'28390733
Email: p;avinwani@wallaceoarma.net
institution@wallacePharma.net
ms379@hotmail,com
Fax No (if any): 124-2821060
Email:institutionalhead@windlasbiotech.com
GST as applicable willwhere no tax has been approved.
Supply to be made directly.
Delivery within
&a
7215 Muradpura(OrangPura) Dhar
Road Near Kalaria Indore M.P. Pin
453001
Mobile/ Tel No: 8435501868 /843s501867
Fax No (if any): 073L-2435123
Emaili info@zenithdrugs.com
Vendor NameZUVENTUS HEALTHCARE
LIMITED
Vendor NameZim Laboratories Limited
Mobile/ Tel No: 9818678219
/9823089 1 2sl 07 118-27 147 0 | 480
Emaill adminot@zimlab.in'
tendercell@zimlab.inriaz. ka ma I *6zim lab. i n
Office No. 5119, 5th Floor, D Wing
Oberoi Garden Estates, Chandivali;
Andheri (E), Mumbai 400 072.
Mobile/ Tel No: 9820511787 /022 3061 0000
Fax No (if any): 022 2847 2829
Emai!: nilesh.nabar@zuventus.com
Sheetal.khanvilkar@zuventus.com
Term 1
GST as applicable will be extra except for items
where no tax has been approved.Term 2
Term 3 If at any time documents submitted/
information given by the firm in the tender is
el er uglr*, waa rd II beeronls thfo nu tod be
cen ledIca
made.d rectyu be5 p
Delivery within
of dispatch) ofbasis
6(six) weeks (of the actual date
supply order on FOR Destination
GST
whe
except for itemsas ap ip
found to be
cancelled,
neous, the award will be
in thIf ti
by
submitted/e tender isinformation
false/ erro
3
Supply to be mTerm 4
ks (of the actual dates weenDelive 6(rynoFOn tiDesti naRu rdeo oIp lyp
Term 2 GST as a
whele 1o
pplicable will be extra except for items
tax'has been approved.
Term 3 documents submitted/If at any time
cancelled.
Supply to be made directlY.
Page 15 of 17
Vendor NameZENITH DRUG PvT LTD
B-2U27, MIDC Area, Kalmeshwar-
441501 Dist. Nagpur
Delivery within 6(six) week (of the actual date
of dispatch) of supply order on FOR Destination
basis
Term 1
Term 2
basis
1
information given by the firm in the tender is
found to be false/ erroneous, the award will be
Term 4
Vendor NameZYDUS HEALTHCARE UMITED
Scheme No. 63, Survey No. 536,
Khoraj (Gandhinagar), S,G.
Highway, Nr. Vaishnodevi Circle,
Ahmedabad-382481
Mobile/ Tel Nor 98
079-26868100
11303727 I
Fax No (if any)r 079-26868100
Email : sandeep.sarkar@zyduscadila.com
Term 1 Delivery within 6(six) weeks (of the actual date
of dispatch) of supply order on FOR Destination
basis
Term 2 GST as applicable will be extra except for items
where no tax has been approved.
Teim 3 submitted/the tender is
award will be
fi
be
cancelled.
Term 4 Supply to be made directly.
Page L7 ol L7
Index 143C
SNo ItemNo.
Page
no
I 33
Bronchodilator Syp-
Each 5ml to contain: Theopyllin Ethanoate Of Piperazine 80m9,
Eph. Hcl.12mg, Guaiphenesin 50m9, Alcohol 0.55m1, Absolute
Alcohol Content 10.44 o/o. 1
z 60
Frusemide Tab/Gp-Each Tab/Gp to contain: Frusemide 40mg 1
3
Isoxsuprine Inj-Each ml to contain: Isoxsuprine 5mg 1
4 7tHeparin Sodium Inj-Each ml to contain: Heparin Sod. 5000 IU 1
5 75
Flunarizine Tab/Gp-Each Tab/Cap to contain: Flunarizine 10mg 7
6 97
Fluoxetine Tab/Cap-
Each Tab/Gp to contain: Fluoxetine 20mg 7
7 98
Phenytoin Sodium Tab/Cap-
Each Tab/Cap to contain: Phenytoin Sodium 100ms 2
I 103
Trihexyphenidyl Tab/Cap-
Each Tab/Gp to contain: Trihexyphenidyl Hydrochloride 2mg 3
9 362Budesonide Inhaler-Each Metered Dose to contain : Budesonide 100 mcg 3
10 365
Losartan+Hydrochlorthiazide Tab/Cap-
Each Tab/Cap to contain: Losartan Potassium
Hydrochlofthiazide 12.5 mg
50 mg,
3
367
Fenoflbrate Tab/cap-
Each Tab/Cap to contain: Fenofibrate ( Micronised ) 200 mg 4
421
Ipratropium + Salbutamol Inhaler-
Each l4etered Dose to contain: Ipratropium
Salbutamol LP. ioomcg
I.P.20mcA.,4
422
Amiodarone Tab/Gp-Each Tab/Cap to contain: Amiodarone Hcl 1Qomg 4
L4
Indapamide SR Tab/Gp-Each SR Tab/Cap to contain : Indapamide 1.5 mg
15 429Clopidogrel Tab/Cap-
Each Tab/Cap to contain: Clopidogrel 75mg
47tfianeptine Tab/Cap-
Each Tab/Cap to contain: Tianept ine Sodium 12.5m9 5
17
Ipratropium Resp. Soln-
Each ml to contain:I ratro um Bromide 250 m 6
516
Etophylline & Theophylline Syp-
Each 5 ml to contain: h line 45.5 Theo lline 14m 6
i9 518
Cough Sedative Syp-
Each 5ml to contain: Chlorpheniramine Meleate 2.5m9,
Guai enesin 100 Nosca ine 15m Sodium Citrate 60 m 6
20 521
Tranexamic Acid Tab/Cap-
Each Tab Ca to contain: Tranexamic Acid 500m 7
21 s22Tranexamic Acid Inj-Each 5ml to contain: Tranexamic Acid 500m 7
5
Page 1of 8
Item Description
63
II
11
12
13
425
I
ls
16
481
18
I
Index 143C
SNo ItemNo.
Item Description Page
no
22 540
Sulbutiamine Tab/Gp-Each Tab/Gp to contain: Sulbutiamine 200m9 7
23 550
Fluticasone+Salmetrol Rotacap-
Each Rotacap to contain: Fluticasone 250 mca, Salmetrol 50
mcg 8
24 574
Metoprolol Inj-Each ml to contain: Metoprolol 1mg 8
25 580
Coagulant Solution-Each ml to contain: Aqueous Solution Of Haemocoagulase
Isolated From Bothrops Atrox Or Bothrops lararaca 0.2CU,
Chlorhexadine Gluconate Soln.0. lpercent (As Preservative),Water For Inject i9n Q.s I
26 1032
Etophylline & Theophylline Tab/Cap-Each Tab/Cap to colltain: Etophylline 77 mg,Theophylline 23 mg 9
27 1041
Salbutamol + Beclomethasone Inhaler-Each Metered Dose to contain: Salbutamol 100 mcg.,Beclomethasone Di onate 50 mcg. 9
28 1050
Pediatric Cough Linctus Syp -
Each ml to contain : Noscapine 1.83m9, Citric Acid 5.8m9, Sod
Citrate 0.67m9, Amm . Chloride 7mg 9
29 1055
Bisoprolol Tab/Cap-Each Tab/Cap to conta in: Bisoprolol Fumerate 5 mg 10
30 1063
Trimetazidine Ta b/Cap-Each Jeblcap to contain: Trimetazidine Hcl 20 mg 10
31 1074Isoxsuprine Tab/Cap-Each Tab/Gp to contain: Isoxsuprine Hcl 10 mg 10
32 1078
Haemo-Coagulant Inj-Each ml to contaln : Aqueous Solution Of Haemocoagulase (OneI U/CU/NIH Unit) Isolated From Venom Of Bothrops, JararacaOr Bothrops Atrox Containing Sodium Chloride 0,9% 10
33
Nimodipine Tab/Cap-Each Tab/Cap to contain : Nimodipine 30 mg 11
34 1131
Sodium Valproate Tab/Cap -Each Tab/Gp to contain: Sodium Valproate 200mq. 11
2( tt32Levodopa & Grbidopa Tabi Gp-Each Tab/Cap to contain: Levodo pa 250 mg, Grbidopa 25 mq 72
36 1348
Valsartan Tab/Gp-Each Tab c.a to contain: Valsartan 72
37 1349
l,letolazone Tab/Cap-Each Ta Cap to contain Metolazone 5mg tz
38 1370 Each Tab Ca to contain: Torsemide 10m 13
39 t372 13
40 1393
Mefenamic + Tranexamic Acid Tab/Cap-Each Tab/Gp to contain: Mefenamic Acid 250m9, TranexamicAcid 500 13
t724
Torsemide Tab/Gp-
Perindopril + Indapamide Tab/Cap-Each Tab/Cap to contain: Perindopril Erbumine 4mg,Indapamide 1.25mq
PaBe 2 of 8
SNo ItemNo.
Item Description Page
no
4t t420Telmisartan Tab/Cap-
Each Tab/Gp to contain: Telmisartan 40mg 74
47 14ZlPerindopril + Amlodipine Tab/Cap-
Each Tab/Cap to contain: Perindropil 4mg, Amlodipine 5mq
43 1461
Hydroxyzine Hydrochloride Tab/Cap-Each Tab/Gp to contain: Hydroxyzine Hydrochloride 25mq I4
44 1.522
Inhaler -
Each Metered Dose to contain: Ipratropium l:}mq,Levosalbutamol 50mcg 15
45 t524Budesonide Respule-
Each 2ml to contain Budesonide 1mg Steriod Nebulizing Fluid 15
1525
llotropium Bromide Rotacap-
Each Rotacap to contain :'Iiotropium Bromide IPIBP Eqv. to'1-iotro ium Bromide Monoh rate 18mcg.
47 1530
lvabradine Tab/Cap-
Each Tab/Cap to contain: Ivabradine 5mg
48 1668
Olmesartan Tab/Cap-
Each Tab/Cap to contain : Olmesartan 20mg 77
49
Haemostatic-
Each 5ml to contain: Haemostatic Matrix With Prefilled GelatinGranules In Syringes 17
50 7674Sumatriptan Tab/c.ap-Each Tab/Cap to contain: Sumatriptan 50mg 18
51
Citicoline Tab/Cap-Each Tab/Cap to contain: Citicoline 500 mg
52 1682
Divalproex Sod. Tab/Cap-Each SR/ER/CR Tab/Cap to contain: Divalproex Sod. 250mq 19
53
Divalproex Sod. Tab/Cap-
Each SR/ER/CR Tab/Gp to contain: Divalproex Sod. 500mq 19
54
Inhaler-7749 Each Metered Dose to contain: Levosalbutamol Tartrate 50mcg 70
1751
Nebivolol Tab/Cap-Each Tab/Cap to contain: Nebivolol 5mg zo
56 1752
Tenecteplase 40mg Inj-Each Vial to contain: Tenecteplase 40mg 20
57 1754
Indapamide SR + Amlodipine Tab/Gp-Each Tab/Gp to contain: Tab/Gp Indapamide SR 1.5 mg,Amlodipine Besylate Equivalent To Amlodipine 5 mg
58 1840
Inhaler-
Each Delivered Dose to contain: Salmetrol Xinafoate IP
Equivalent to Salmetrol IP 25 trg, Fluticasone Propionate IP
250p9, Excipients & Propellant 1, 1,1.2 Tetrafluoro Ethane HFA
134a
Autohaler-
Each Delivered Dose Of Autohaler to contain: Salmeterol (As
Salmeterol Xinafoate) IP 25 mcg, Fluticasone Propionate IP
250mcA Suspended In Propellant 134a Q.S. (Contains AbsoluteAlcohol Ip 5olo v/v) 2t
Index 143C
l4
16
2t
2l
59
Page 3 of 8
z*b 16
1670
1681 18
1683
55
1843
I
I
77
75 2067
Index 143C
Metoprolol Succinate SR Tab/Gp-Each SR Tab/Cap to contain: Metoprolol Succinate 23.75m9
uivalent To Meto rolol Tartrate 25m 22
7?
25
26
SNo Item Description
no
60
1869 22
62 1870
Amisulpride Tab/Gp-Each Tab/Cap to contain: Amisul
Each Tab/Cap to contain Quetiapine 25 mg
pride 50mg
Quetiapine Tab/Cap-
1871Quetiapine Tab/Cap-
Qp to contain: Quetiapine 100 mgEach Ta 2363
1873
Paroxetine CR Tab/Gp-Each CR Tab/Cap to contain: Paroxetine 25mI
65I Levetiracetam Tab/Cap-
p to contain: Levetiracetam 500mq1879 I Each Tab/Ca 24
66 1880
Levetiracetam Tab/Cap-
to contain: Levetiracetam 250Each Tab ca 24
67 1883 25
68 20t4 to contain: Montelukast Sodium 10m
Each Ta ine 100mG to contain: Lamotr
Each Ta G
Lamotrigine Tab/Cap-
Montelukast Sodium Tab/cap-
69 2015
Beclomethasone Dipropionate IP 200mcg (HFA Technology)Inhaler-
Each I'4etered Dose to contain: Beclomethasone Dipropionate Ip2Q0mcg (HFA Technology)
70 20t9
Indapamide (As SR)1.5m9 , Amlodipine B€silate Equivalent toAmlodipine 2.5m9, Excepients QS Film Coated Bi-LayeredTab/Cap-
Each Film Coated Bi-Layered Tab/Cap Contains: Indapamide (As
SR)1.5m9 , Amlodipine Besilate EquvalentTo Amlodipine 2.5mg,Excepients QS
Acenocoumarol / Nicoumalone Tab/Cap-Each Tab/Cap to contain: Acenocoumarol / Nicoumalone 2mq 26
2060
Ambroxol + Terbutaline Tab/Gp-Each Uncoated Tab/Gp to contain; Ambroxol Hrdrochloride 30
Terbutaline Sul hate uivalent to Terbutaline 2,5 26
2061
Ambroxol + Terbutaline Syp-
Each 5 ml to contain: Ambroxol Hrdrochloride IP 30 mg,Terbutaline Sulphate IP Equivalent to Terbutaline 2.50 mg,Guaiphenesin IP !0 49, Menthol IP 0.5 mg
74
Inhaler-
Each Inhaler to contain: Fluticasone Propionate 250mcg,Formoterol Fumarate 6m
76 2068
S(-)Metoprolol TabiCap-Each CR/PR/DR/SR/MR Tayc;,p to contain : S(-)Metoprotot
.toS rolol Tartrate 25MetoSuccinate 23.75 m
50m
z8
Page 4 of 8
ItemNo.
Page
1845
b1
64 23
I
2063
SC)Metoprolol Tab/Cap-Each Prolonged Release Film Coated Tab/Gp to contain : S(-
)Metoprolol Succinate 47.50 mg Eqv. to S(-) Metoprolol Tartrate
25
I
2022
73
Index 143C
SNo Item Description Page
no
77 2069Tlcagrelor Tab/Cap-Each Tab/Cap to contain:Ticagrelor 90mg 28
2070
Ivabradine Tab/Cap-
Each Film Coated Tab/Cap to contain: Ivabradine Hcl Equivalent
To IvabradineT.5mq 28
79 2074
Indapamide + Amlodipine Tab/Gp-Each Film Coated Bilayered Tab/Cap to contain Indapamide (As
Sustained Release) 1.5m9 and Amlodipine Besilate Equivalent toAmlodipine 10mg 28
80 7076
Micronised - Purified Flavonoid Tablcap-Each Film Coated Tab/Cap to contain: Micronised - Purified
Flavonoid Fraction 1000m9-Composed Of Diosmin 900m9(90o/o) And Flavonoids Expressed As Hesperidin 100mq (100/o) 29
81 2077
Hemostat-
Each PFS to contain: Hemostatic Matrix With Thrombin InPrifilled Syringe 10ml
82 2078
Apixaban Tab/Gp-Each Film Coated Tab/Gp to contain: Apixaban 2.5mq 29
83 2079Apixaban Tab/cap-Each Film Coated Tab/Gp to contain: Apixaban 5mq 30
84 2080
Dabigatran Tab/Cap-
Each p to contain: Dabigatran Etexilate 110 mg 30
85 2081
Anticoagulants-
Each Kit to contain:Two Componant Fibrin Sealant WithSylthetic Aprotinin (4ml) 31
86 2203
Terbutaline + Guiaphenesin + Ambroxol Syp-
Each 5 ml to contain: Terbutaline I.P 1.25m9 + Guiaphenesin
I.P + Ambroxol I.P 15mg Syrup Base QS 31
87 2204
Dextromethorphan + CPM Syp-
Each 5 ml to contain: Dextromethorphan I.P 10mg +Chlorpheniramine l4aleate I.P 2mg Syrup Base QS 37
88 2205
Ibutilide-Each ml to contain: Ibutilide Fumarate 0.1m9 ( Equivalent ToIbutilide Freebase 0.087m9), Water For injection 32
89 2207
Glyceryl Trinitrate Spray-
Each Metered Dose to contain: Glyceryl Trinitrate Spray -0.4 Mq ?1
90 2208
Human Albumin-
Each Bott to contain- Human Albumin 25o/o 100 ml In Flexible,
Self Collapsible- Closed System Baqs 33
91 2209
Emicizumab Inj-Each Vial Contains : Emicizumab 30mg For Sub Cut Injection (R-
DNA Oriqin) 33
92 22l0
Emicizumab Inj-Each Vial Contains : Emicizumab 60mg For Sub Cut Injection (R-
DNA Oriqin) 33
Page 5 of 8
ItemNo.
78
29
Index 143C
SNo ItemNo.
Item Description Page
no
93 22tt
Micronized - Purified Flavonoid Tab/Cap-
Each Film Coated Tab/Cap to contain : Micronized - Purified
Flavonoid Fraction 500m9 Composed Of Diosmin 450m9 (90%)
And Flavonoids Expressed As Hesperidine 50mq (10o/o) J.i
94 2299
Telmisartan Tab/Cap:
Each Tab/Cap to contain: Telmisartan 20mg 34
95 2302Dabigatran Etexilate Tab/Cap-
E.in"i.ulc"E" ilnt"nl OJuiqutran Etexitate lsomq 51
q6 2303
Acetyl Sdlicylic Acid + Atorvastatin Tqblcap-Each TdblGD to contaih: ACetyl Salicylic Acid 75m9,Atorvastatin 20mq 35
97 2306
Diltiazem CR/ SR/ DR/ tvlR Tab/Gp-Each CR/ SR/ DR/ MR Tab/Cap to contain: Diltiazem 90mq 35
98 2309
Codein Lint. Syp/Susp-
Each sml to contain: Chlorpheniramine Maleate 4mg, Codeine
Phosphate 1omg 3s
99 2312ftriptyline
Gabapentin + Nortriptyline Tab/Cap-
Each Tab/Cap to contain: Gabapentin
10mg
100m9, No
36
100 2377
balin Tab/Cap-PLAIN/SR/CR/DR/ER/MR Tab/Cap to contain: Pregabalin
Prega
Each
75 36
101
Beclomethasone Inhaler-Each Metered Dose to contain: Beclomethasone Dipropionate100mcg. 36
102 1043a
Salbutamol Rotacap-
Each Rotacap to contain : Salbutamol 200mcg
103 1056a
Metoprolol Tab/Cap-
Each Tab/Gp to contain: 37
104 1060a
Iso-Sorbide Mononitrate Tab/ p-
Each Tab/Cap to contain: Iso-Sorbide-S-Mononitrate 20 mg 37
1067b
Prazosin SR Tab/Cap-
Each SR Tab/Gp to contain: Prazosin Hcl 2.5 mg
106 1067c
Prazosin SR Tabicap-Each SR Tab/Cap to contain: Prazosin Hcl 5mg 38
\07 1068b
Ramipril Tab/ Cap-
Each Tab/ Cap to contain: Ramipril 2.smq 39
108 1068c
Ramipril Tab/Cap; '-
Each Tab/Cap to contain: Ramipril smg 39
109 1115b
Phenobarbitone Tab/Gp-Each Tab/Cap to contain: Phenobarbitone-30m9 40
110 1727 a
Carbamazepin CR Tab/Cap-
Each CR Tab/Cap to contain: Carbamazepin 200m9 40
111 1370b
Torsemide Tab/Cap-Each Tab/Cap to contain: Torsemide 20mq 40
Page 5 of I
1040b
105 38
Index 143C
SNo ItemNo.
Item Description Page
no
tt7 1430b
Mirtazapine Tab/Cap-
Each Tab/Cap to contaln: Mirtazapine 15mg 47
113 324a
Clobazam Tab/Cap-
Each Tab/Cap to contain: Clobazam 5 mg 47
t14 324b
Clobazam Tab/Cap-
Each Tab/Cap to contain: Clobazam LP.10 mq 41
32bEach ml to contain: Salbutamol Sulphate Eqv. to Salbutam
mg. In Normal Saline Soln.
ol 542
116 336b
Grvedilol Tab/Cap-
Each Tab/Cap to contain: Carvedilol 6.25m9
117 366a
Enoxaprin Inj-Each PFS to contain Enoxaprin Sodium 20 mg / 0.2 ml.
118 366c
Enoxaparin 60 mg/0.6m1 Inj-Each PFS to contain: Enoxaparin 60 mg/0.6m1 43
119 420a
Fluticasone + Salmeterol Inhaler-Each Metered Dose to contain: Salmeterol
50mcg
25mcg, Fluticasone
43
t20 423aNicorandil TablCap-Each Tab/Cap to contain: Nicorandil 5mg 43
72t 433b 44
722 44b
Propranolol Tab,/ Ca
in: Propranolol 40mg
p-
Each conta 44
tz3 470aPerindopril Tab/Cap-Each Tab/Cap to contain: Perindopril 2mq 44
t74 470cPerindopril Tab/Cap-
Each Tab/Cap to contain: Perindopril Erbumine 8mg 45
125 473aResperidone Tab/cap-Each Tab/Cap to contain: Resperidone 1mq 45
726 474bOlanzapine Tab/Cap-Each Tab/Cap to contain: Olanzapine 5mg 45
727 475bHaloperidol Tab/Cap-
Each Tab/Cap to contain: Haloperidol 5mg 46
128 477 a
Amitriptyline Tab/Gp-Each Tab/Cap to contain: Amitriptyline 10mg
LZg 477bAmitriptyllne Tab/Cap.
25mqEach Tab/Cap to contain: Amitriptyline 46
130 486a
Paroxetine Tab/Gp-Each Tab/Cap to contaln: Paroxetine 1Omg 46
131 486b
Paroxetine Tab/Cap-
Each Tab/Cap to contain: Paroxetine 20mg
525a
I4etoprolol ER Tab/Gp-Each ER Tab/Cap to contain: Metoprolol Succinate 47.5m9
Equivalent to Metoprolol Tartrate 50mq. 47
133 527a
Gabapentin Tab/Cap-
Each Tab/Cap to contain: Gabapentin 300m9
Page 7 of 8
115
42
42
Sodium Valproate + Valproic Acid CR Tab/Cap-Each CR Tab/Cap to contaln: (Sodium Valproate + Valproic Acid)Eqv. to Sodium 500mq.
46
47
132
48
aEl
r-
Index 143C
SNo ItemNo.
Item Description Page
no
734 555a
Clozapine Tab/Cap-Each Tab/Cap to contain : Clozapine 25mg 48
135 555b
Clozapine Tab/Cap-
Each Tab/Gp to contain: Clozapine 100m9 48
136 556a
Escitalopram Tab/cap-Tab/Gp to contain: Escitalopram 10 mqEach 49
737 556b : Escitalopram 20 mq 49
138 557aDalteparin Sodium Inj-Each PFS to contain: Dalteparin Sodium 2500 IU Units 49
139 557b
Inj-5000 IU UnitsnEach PFS to
Dalteparin
50
140 68a 50
141 74a 50
Page I of 8
Sodium
Ethamsylate Tab/Crp-Each Tab/Cap to contain Ethamsylate 250 mqStreptokinase Inj-Each Vial to contain: Streptokinase I.P 7.5 Lac IU
Employes' StaE fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/12lf42C-L46C|zOLg-Med V FOR RC 143C
Valid from Thursdan October 14U, 2O2L to Tuesday, October 315t 2023
PackingDrug Description
Firm Name Firm Rate/unit Packing
Preference De*ription of stores ac@pted
200m1 Bottle33 Bronchodilator Syp-
Each 5ml to contain:
Theopyllin Ethanoate Of Piperazine 80m9,
Eph. Hcl.12mg, Guaiphenesin 50m9,
Alcohol 0.55mlt'Absolute Alcohol Contqn!.!q419lo.:
HindustanLaboratoriesLimited
Juggat Pharma(Pharma DivisionOf Jagdalelndustries PrivateLimited)
Sai Parenterals Pvt.Ltd.
0.36 Per 10 Tabsl Tab/Cap
47.24 HIPH E
200m1 Bott SAME AS I
Rupees Forty seven AND Paise Two Four Only
ITEM200 mlBottle.,
R
Rupees Nil AND Paise Three Six Only
63 Isoxsuprine Inj- 2ml Vial/Amp
Each ml to contain: Isoxsuprine smg
2ml Amp FIRST TIDITAN9.00 Per2ml ViaUAmp IN ITEM
Rupees Nine Only
77 Heparin Sodium Inj-Each ml to contain: Heparin Sod.5000 IU
5ml Vial/Amp
FIRST SAME AS IN ITEM195.O0 Per l Vialsml ViaUAmp
Rupees One Hundred Ninety Five Only J_.^--*/-
Page 1 of 50
ftem No
MicronPharmaceuticals
FIRST
60 Frusemide Tab/Cap-
Each Tab/Cap to contain: Frusemide 40mg
1 Tab/Cap
Em ptoy@s' State fnsuran@ Corporation
Rate Schedule of Running Rate contract No. U-25/121142C-L46C12OL9-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31"t 2023
ftem No
aceptedPreferenceFirm Rate,/unit
Firm Name
75 Flunarizine Tab/CaP-
Each Tab/Cap to conta in: Flunarizine 10mq
FDC Limited
Fluoxetine Tab/CaP-
Each Tab/Cap to contain: Fluoxetine 20mg
0.39 Perl Tab/Cap
0.58 Perl Tab/Cap
1.50 Perl Tab/Cap
o.30 Perl Tab/Cap
0.36 Perl Tab/Cap
0.41 Perl Tab/Cap
10Tabs FIRST
10 TabS FIRST
10 Tabs
120 Tabs THIRD
Revat LaboratoriesPvt. Ltd.
Zydus HealthcareLtd
Abbott IndiaLimited
Rupe Nil AND Paise FiYe Eight OnlYo
Rupees One AND Paise Six Zeru OnlY
98 Phenytoin Sodium Tab/CaP-
Each Tab/Cap to contain: Phenytoin Sodium 100m9
l Tab/Cap
10 Tabs FIRST SAME AS IN ITEM
Rupees Nil AND PaiseThre Six OnlY
SECOND FLOATIN 20 MG
SAME AS IN ITEt"l
EPTOINSAME AS IN ITEM
Rupe Nil AND Paise Thre Zerc OnlY
looTabs SECOND EPSOUNSAME AS IN ITEM
Rupees Nil AND Paise Four One Onl2
Page 2 of 50
FirmPackino
De*ription of storcs
HabPharmaceuticals &Research Ltd
MesmerPharmaceuticals
FLUNARIN 10 MG
SAME AS IN ITEM
t
Rupees Nit AND Paise Three Nine Only
97 1 Tab/Cap
ELEVAT
SAME AS Iil ITEM
t.
Druo
1 Tab/Cap
Em ployees' State fnsura nce Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|2OL9-Med V FOR RC 143C
Vafid from Thursday, October L4tj 2O2L to Tuesday, October 31't 2023
ftem No Drug Description Packing
Firm Name Firm RaE/unit Packing
Prefercnce
103 Trihexyphenidyl Tab/Cap-
Each Tab/Cap to contain:Trihexyphenidyl Hydrochloride 2mg
1 Tab/Cap
362 Budesonide Inhaler-
Each Metered Dose to contain :
Budesonide 100 mcg
Equal to or more than 120 MDI
2OO MDT FIRST BUDECORT 1OO CFC FREE INH(WITH DOSE COUNTER)
SAME AS IN ITEM
Ru6es Nil AIVD Paise Thrce Five Only
MicronPharmaceuticals
Midas CarePharmaceuticals
Pvt. Ltd.
HabPharmaceuticals &Research Ltd
O.72Per1 Tab/Cap
0.84 Perl Tab/Cap
0.35 Perdose
Rupees Nil AND Paise Three Six Only
l0Tabs FIRST LOSARK-H
SAME AS IN ITEM
MacleodsPharmac€uticalsLimited
Rupees Nil AllD Paise Eight Four Only
15 Tabs SECOND OMNTTAN HSAME AS IN ITEM
365 Losartan+Hydrochlorthiazide Tab/Cap-Each Tab/Cap to contain:Losartan Potassium 50 mg,Hydrochlorthiazide 12.5 mq
1 Tab/Cap
Page 3 of 50
Dexription of stores acepted
10 Tabs FIRST SAME AS IN ITEM
Rupees Nil AND Paise Seven Two Only
Cipla Limated
0.36 Per 240 MDI SECOND BUDESONE 1OO INHATATIONdOse SAMEASIN ITEM
1.07 Perl Tab/Cap
Rupees One AND Paise Zero Seven Only
/1*u
Employees' State fnsurance Corporation
Rate Schedute of Running Rate Contract No. U-25/12l142C-l46Cl20l9-Med V FOR RC 143C
Valid from Thursday, October 1#h 2021 to Tuesday, october 31't 2023
Packinqftum No Drug Description
Firm Name Firm Rate/unit Packing
De*ription of s'tores ac@pbd
367 Fenofibrate TabiCap-
Each Tab/Cap to contaln:
Fenofibrate ( Micronised ) 200 mg
1 Tab/Cap
MicronPharmaceuticals
SignaturePhytochemicallndustries
1.80 Perl Tab/Cap
0.90 Perdose
2.40 Perl Tab/Cap
10 Tabs FIRST SAME AS IN ITEM
Rupees One AND Paise Eight Zero Only
USV Private Limited 2.68 Per Strips of SECOND UPICARD 20OMG
l Tab/Cap 10 Caps SAME AS IN ITEM
Ipratropium + Salbutamol Inhaler-
Each Metered Dose to contain:
Ipratropium I.P.20mcg., Salbutamol I.P.100mcg
Equal to or more than 120 MDI
240 MDI FIRST SAUPRAIR HFA INHALATIONSAME AS IN ITEM
Rupees Nil AND Paise Nine Zero Only
Amiodarone Tab/Cap-
Each Tab/Cap to contain: Amiodarone Hcl 100m9
1 Tab/Cap
10 Tabs FIRST SAME AS IN ITEM
Rupees Two AND Paise Four Zeru Onlln
Page 4 of 50
Preference
Rupees Two AND Paise Six Eight Only
42t
Midas CarePharmaceuticalsPvt. Ltd.
422
Em ployees' State fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25l12l142C-L46C|zOL9-Med V FOR RC 143C
Valid from Thursday, October L4th 2O2L to Tuesday, October 31"t 2023
ftem No Drug Description Packing
Firm Name Firm Rate/unit Packing
Prefercnce Description of storcs ac@pted
425 Indapamide SR Tab/Cap-
Each SR Tab/Cap to contain : Indapamide 1.5 mg
1 Tab/Cap
Modi MundipharmaPrivate Limited
2.5O PerI Tab/Cap
10 Tabs FIRST INDICONTINSAME AS IN ITEM
Ruryes lwo AND Paise Five Zeto Only
5.90 Per 10 Tabs SECOND NATRILIX SRl Tab/Cap SAME AS tN ITEM
429 Clopidogrel Tab/Cap-Each Tab/Cap to contain: Clopidogrel 75mq
1 Tab/Cap
PulsePharmaceutical ArtLtd
lark Laboratories(India) Ltd.
Themis MedicareLimited
SerdiaPharmaceuticals(India) PrivateLimited
O.72Perl Tab/Cap
4.77 Perl Tab/Cap
10 Tabs FIRST
10 Tabs FIRST STABLONSAME AS IN ITEM
Rupees Nil AND Paise Seven Two Only
CTOTREL 75SAME AS IN ITEM
Rupees Nil AND Paise Seven Eight Only
0.82 Per 10 Tabs THIRD THEMIGRETl Tab/Cap SAME AS IN ITEM
Rupees Nil AND Paise Eight TWo Only
47t Tianeptine Tab/Cap-
Each Tab/Cap to contain:
lianeptine Sodium 12.5m9
l Tab/Cap
Ru$es Four AND Paise Seven *ven Only
Page 5 of 50
SerdiaPharmaceuticals(tndia) PrivateLimited
Rupees Five AND Paise Nine Zeto Only
0.78 Per 10 Tabs SECOilD CLOPILARl Tab/Cap SAME AS IN ITEM
f*',*
Employes' State fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/121142C-t46Clz0l9-Med V FOR RC 143C
Valid from Thursdan October l4th 2O2L to Tuesday, October 31.t 2023
ftum No Drug Description Packing
Firm Name Firm Rate/unit
FirmPacking
Prefercnce Dexription of stores ac@phd
481 Ipratropium Resp. Soln-
Each ml to contain:Ipratropium Bromide 250 mcg
15ml Eottle
Cipla Limated
RuBes Fouften AND Paise Nine Zeru Only
Etophylline & Theophylline Syp-Each 5 ml to contain:Etophylline 46.5m9. , Theophylline 14mg
100m1 Bottle
14.90 Per15ml Bott
14.40 Per100m1 Bott
33.74 Per100m1 Bott
15mlBottle
100m1Bottle
100m1
Bottle
FIRST
FIRST
FIRST
Rupes Fourten AND Paise Four Zero Only
IPRAVENT RESPIRATOR SOI.SAME AS IN ITEM
DUOLLINSAME AS IN ITEM
HIMALEATE
SAME AS IN TTEM
MicronPharmac€uticals
HindustanLaboratoriesLimited
Rupees Thifi Thre AM Paise Seven Four Only
518 Cough Sedative Syp-
Each 5ml to contain:Chlorphen iramine Meleate 2.5m9,Guaiphenesin 100m9, Noscapine 15m9,Sodium Citrate 60 mg.
100m1 Bottle
Page 6 of 50
516
f"ry
Employees' State fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-251 L2l142C-t46ClzOL9-Med V FOR RC 143C
Valid from Thursday, October L4$ 2O2L to Tuesday, October 31't 2023
Drug Description Packing
Firm Name Firm Rate/unit Packing
Preference Description of sbres ac@pted
52r Tranexamic Acid Tab/Cap-
Each Tab/Cap to contain: Tranexamic Acid 500m9
1 Tab/Cap
1O Tabs FIRST
l Amp FIRST
GYNAEPIL 5OO
SAME AS IN ITEM
GYNAEPILSAME AS IT{ ITEM
Rupees Four AND Paise Six Five Only
6.33 Per 6Tabs SECOND TRENAXAS00l Tab/cap SAMEAS IN ITEM
Psychotropi6 IndiaLimit€d
Rupees Six AND Pai* Thrce Thr* Only
FDC Limited 7.50 Per 10 Tabs THIRD CLIP 500l Tab/Cap SAME AS rN ITEM
Ru@es Seven /lND Paise Five Zerc Only
522 Tranexamic Acid Inj-Each 5ml to contain: Tranexamic Acid 500m9
1 Amp
12.60 Perl Amp
Rupees Twelve AllD Pai* Six Zeto Only
540 Sulbutiamine Tab/Cap-
Each Tab/Cap to contain: Sulbutiamine 200m91 Tab/Cap
12.07 PerI Tab/Cap
Rupees Tweltle AND Pai* Zeto *ven Only,
Page 7 of 50
ftem No
Psychotropics India 4.65 PerLimited l Tab/Cap
MacleodsPharmaceuticalsLimited
10 Tabs FIRST AR,CALION
SAME AS IN ITEM
SerdiaPharmaceuticals(India) PrivateLimited
*<
Employees' State Insu ra nce Corporation
Rate Schedule of Running Rate Contract No. U-25/121142C-l46Cl20l9-Med V FOR RC 143C
Valid from Thurcday, October L4th 2O2L to Tuesday, October 315t 2023
f@m No Drug Description Packing
Firm Name Firm Rate/unit Packing
Prefercnce Dexription of stores accepted
550 Fluticasone+Salmetrol Rotacap-
Each Rotacap to contain: Fluticasone 250 mcg,
Salmetrol 50 mcg
l Rotacap
Cipla Limited 1.02 Per1 Rotacap
30 CapsBottle
FIRST
Zydus HealthcareLtd
MacleodsPharmaceuticalsLimited
Rupees One AND Paie Zero Two Only
Rupees One AND Paie One *ven Only
1.23 Per 30 Caps THIRD FIUTROL 2S01 Rotacap Bottle (HARD GE|-ATIN CAPSULE)
SAME AS IN ITEM
Rupe* One AND Pai* Two Thrce Only
574 Metoprolol IniEach ml to contain: Metoprolol lmg
5ml Vial/Amp
Cipla Limited
Juggat Pharma(Pharma DivisionOf JagdaleIndustries PrivateLimited)
75.50 Per10ml Bott
R Twelve
12.00 PerSml Vial/Amp
5ml Vial/ FIRSTAmp
METOLAR
SAME AS IN ITEM
BOTROCTOT TOPICALSOLUTIONSAME AS IN ITEM
FIRST
Rupes *venty Six AND Pai* Five Zeru Only 7iz o<l-*a-,>l*r.+
/.-
sB0 Coagulant Solution-Each ml to contain: Aqueous Solution OfHaemocoagulase Isolated From Bothrops Atrox OrBothrops Jararaca 0.2CU, Chlorhexadine GluconateSoln.0.lpercent (As Preservative), Water ForInjection Q.S.
10ml Bottle
Page 8 of 50
10mlBottle
SEROFLO 250 ROTACAPSSAlrlE AS IN ITEM
L.l7 Per 30 Caps SECOND FORAIR 250 RESPICAP1 Rotacap Bottle SAME AS IN ITEM
Em ployees' State fnsura nce Corporation
Rate Schedule of Running Rate Contract No. U-25/121142C-L46C|zotg-Med V FOR RC 143C
Valid from Thursday, October L4tn 2O2L to Tuesday, October 313t 2023
ftem No Drug Description Packing
Firm Name Firm Rate/unit Packing
De*ription of stores ac@phd
Etophylline & Theophylline TabiCap-Each Tab/Cap to contain:
Etophylline 77 mg,Theophylline 23 mg
MicronPharmac€uticals
Zydus HealthcareLtd
HindustanLaboratoriesLimited
0.45 Perdose
23.21 Per50ml Bott
240 MDI FTRST
FIRST
O.27 Perl Tab/Cap
10 Tabs FIRST SAME AS IN ITEM
0.33 Per 30 Tabs SECOND DERIPHYLLINl Tab/Cap SAMEAS IN ITEM
Salbutamol + Beclomethasone Inhaler-Each Metered Dose to contain:Salbutamol 100 mcA.,
Beclomethasone Dipropionate 50 mcq.
Equal to or more than 120 MDI
Rupees Nil AND Paise Four Slx Only
Pediatric Cough Linctus Syp -
Each ml to contain : Noscapine 1.83m9,Citric Acid 5.8m9, Sod. Citrate 0.67m9,Amm. Chloride 7mg
50ml Bottle
SALBESONE INHALATIONSAME AS IN ITEM
Rupees fwenty Thtce AND Paise Tluo One Only?
Preference
1032 1 Tab/Cap
Midas CarePharmaceuticalsPvt. Ltd.
Rupees Nil AND Paise Two Seven Only
Rupees llil AND Paise Three fhrce Only
HISCOPINE PAEDIATRICSAME AS IN ITEM
50mlBottle
W
1041
1050
Page 9 of 50
Employes' Sbte fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OL9-Med V FOR RC 143C
Valid from Thursday, October 14d' 2021 to Tuesday, October 31't 2023
ftem No Drug Description Packing
Firm Rate/unit
FirmPacking
Preference Dexription of stores ac@pted
1055 Bisoprolol Tab/Cap-
Each Tab/Cap to contain: Bisoprolol Fumerate 5 mg
1 Tab/Cap
IntasPharmaceuticalsLtd
1.67 Perl Tab/Cap
10 Tabs FIRST
Rapes One AND Pai* Six Seven Only
Trimetazidine Tab/Cap-
Each Tab/Cap to contain: Trimetazidine Hcl 20 mq
l Tab/Cap
Themis MedicareLimited
SerdiaPharmaceuticals(India) PrivateLimited
0.52 Perl Tab/Cap
10 Tabs FIRST THEMIDONSAME AS IN ITEM
6.43 Per lOTabs SECOND FTAVEDON 20l Tab/Cap SAMEAS IN ITEM
1074 Isoxsuprine Tab/Cap-Each Tab/Cap to contain: Isoxsuprine Hcl 10 mg
l Tab/Cap
OverseasHealthcarc Art Ltd
Juggat Pharma(Pharma DivisionOf JagdaleIndustries PrivateLimited)
71.15 Perlm! ViaUAmp
PREGNIN
SAME AS IN ITEM
BOTROPASE INJECTIONSAME AS IN ITEM
1ml ViaUAmp
FIRST
Rupees *venty One AND Paise One Fiye Only
1078 Haemo-Coagulant Inj-Each ml to contain : Aqueous Solution OfHaemocoagulase (One I U/CU/NIH Unit) IsolatedFrom Venom Of Bothrops, Jararaca Or BothropsAtrox Containing Sodium Chloride 0.9olo
1ml Vial/ Amp
Page 10 of 50
// frr
Firm Name
BISELECT-5
SAME AS IN TTEM
1063
Rupees Nil AND Paise Five tuw Only
Rupees Six AND Paise Four Thrce Only
0.54 Perl Tab/Cap
10 Tabs FIRST
Rupes llil AND Paise Five Four Only
Employees' State fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OLg-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31't 2023
fEm No Drug Desciption Packing
Firm Rate/unit Packing
Preference Dexiption of stores acepfud
tt24
1131 Sodium Valproate Tab/Cap -
Each Tab/Cap to contain: Sodium Valproate 200m9.
I Tab/Cap
USV Private Limited 3.25 Perl Tab/Cap
10 Tabs FIRST
10 Tabs FIRSTHabPharmaceutacals &Research Ltd
Psychotropics IndiaLimited
Sanofi - Synthelabo(India) PravateLimited
0.80 Perl Tab/Cap
0.86 Per 10 Tabs SECOND TAB VALATE 2OO
l Tab/Cap (ENTERIC COATED GASTRO
RESISTANT TABLET)
SAME AS IN TTEM
Rupees Nil AND Paise Eight Six Only
2.47 Pq 10 Tabs THIRD VALPARIN ALKALTES 2OO
l Tab/Cap (EACH ENTERIC COATED
GASTRO RESISTANT TABLFT)
SAME AS IN ITEM
Ru@es Two AND Paise Four *ven Only
Page 11 of 50
Firm Name
Nimodipine Tab/Cap-
Each Tab/Cap to contain: Nimodipine 30 mg
l Tab/Cap
NIMODIPSAME AS IN ITEM
EPIVALPRATE-2OO(ENTERIC COATED TABLET)
SAME AS IN ITEM
Rupees Thrce AND Paise Two Five Only
Rupees Nil AND Paise Eight Zero Only
Employees' State Insura nce Corryration
Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|2OL9-Med V FOR RC 143C
Valid from Thursday, October t4th 2O2l to Tuesday, October 31't 2023
Drug Description Packing
Firm Name Firm Rate/unit Packing
Prefercnce Description of stores accepted
1t32 Levodopa & Carbidopa Tab/Cap-
Each Tab/Cap to contain: Levodopa 250 mg,
Carbidopa 25 mg
1 Tab/Cap
Rupees Two AND Paise Eight Ze,o Only
1348 Valsartan Tab/Cap-
Each Tab/Cap to contain: Valsartan B0mg
1 Tab/Cap
Sun PharmaLaboratoriesLimited
2,80 Per
I Tab/Cap
6.30 Perl Tab/Cap
10 Tabs FIRST VALSALAR-80SAME AS IN TTEM
10 Tabs FIRST ZYTAND( 5SAME AS IN TTEM
Rupes One AND Paise Nine Eight Only
t349 Ivletolazone Tab/Cap-
Each Tab/Cap to contain Metolazone 5mg
l Tab/Cap
8.11 Per 10 Tabs SECOND METOZ 5 MGl Tab/Cap SAME AS IN ITEM
Rupees Eight AND Paise One One Only
Page 12 of 50
ftem No
Lark Laboratories(India) Ltd.
1.98 Perl Tab/Cap
10 Tabs FIRST SAME AS IN ITEM
Zydus HealthcareLtd
CentaurPharmaceuticalsPrrt. Ltd.
Rupees Six AND Paire Thrce Zerc Only
/"'Y
Employees' State fnsu ra nce Corporation
Rate Schedule of Running Rate Contract No, U-25/12l142C-L46C|zOLg-Med V FOR RC 143C
Valid from Thursday, October 14rh 2O2L to Tuesday, October 31st 2023
Packingfbm No Drug Description
Firm Name Firm Rate/unit Packing
Prefetence Description of storcs ac@phd
t370 Torsemide Tab/Cap-
Each Tab/Cap to contain: Torsemide 10mg
l Tab/Cap
Cipla Limited
IntasPharmaceuticalsLtd
CentaurPharmaceuticalsPt t. Ltd.
SerdiaPharmaceuticals(India) PrivateLimited
HabPharmaceuticals &Research Ltd
MacleodsPharmaceuticalsLimited
7.7O Perl Tab/Cap
10 Tabs FIRST
10 Tabs FIRST
COVERSYT PLUS
SAME AS IN ITEM
CYCKLATRAN-MSAME AS IN ITEM
0.57 Per 15 Tabs FIRST DYTOR 10l Tab/Cap SAME AS IN rTEM
Rupees Nil AND Paise Five Seven Only
1.65 Per 15 Tabs SECOND TOR-10l Tab/Cap SAME AS IN ITEM
Rupees One AND Pai* Six Six Only
1,89 Per loTabs THIRD MELTOR 1OMG
l Tab/Cap SAME AS IN rTEM
Rupees One AND Paise Eight Nine Only
1372 Perindopril + Indapamide Tab/Cap-
Each Tab/Cap to contain:
Perindopril Erbumine 4mg, Indapamide 1.25m9
l TabiCap
Rupees Seven AND Paise Seven Zerc Only
1393 l'lefenamic + Tranexamic Acid Tab/Cap-
Each Tab/Cap to contain: Mefenamic Acid 250m9,
Tranexamic Acid 500m9
l Tab/Cap
Rupees Four AND Paise Nine Zero Only
7.L7Per 6Tabs SECOND TRENAXAMFI Tab/Cap SAME AS IN ITEM
Rupees Seven AND Paise One Seven Only
Page 13 of 50
4.90 Perl Tab/Cap
/^y
Employees' Sbte fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-146C12019-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31't 2023
Drug Description Packing
Firm Name Firm Rate/unit Packing
Preference De*rtption of storcs ac@phd
1420 Telmisartan Tab/Cap-
Each Tab/Cap to contain: Telmisartan 40mg
1 Tab/Cap
0.57 Perl Tab/Cap
15 Tabs FIRST TELDIL 40SAME AS IN ITEM
Rupees Nil AND Pai* Six Nine Only
0.95 Per 10 Tabs THIRD TELMIKAA 40l Tab/Cap SAI.{E AS IN ITEM
Rupees Nil AND Paise Nine Five Only
t42r Perindopril + Amlodipine Tab/Cap-Each Tab/Cap to contain: Perindropil 4mg,Amlodipine 5mg
l Tab/Cap
TroikaaPharmaceuticalsLimited
SerdiaPharmaceuticals(India) PrivateLimited
Psychotropics IndiaLimited
6.45 Perl Tab/Cap
0.79 Perl Tab/Cap
lOTabs FIRST
10 Tabs FIRST
covERsYL - AM 415SAME AS IN ITEM
HYDIL 25SAME AS IN ITEM
Rupees Six AND Pai* Four Five Only
1 Tab/Cap
Rupees Nil AND Paise Seven Nine Only
Page 14 of 50
ftem No
Rupees Nil AND Paise Five Seven Only
Psychotropics India 0.69 Per 10 Tabs SECOND TELPIT 40Limited l Tab/Cap SAME AS IN ITEM
PulsePharmaceutical Pt tLtd
1461 Hydroxyzine Hydrochloride Tab/Cap-
Each Tab/Cap to contain:Hydroxyzine Hydrochloride 25mg
{*
Em ployees' State fnsu ra nce Corporation
Rate Schedule of Running Rate Contract No.U-25lL2lL42C-l46Clz0l9-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31st 2023
ftem No Drug Description Packing
Firm Name Firm Rate/unit
FirmPacking
t522 Inhaler -
Each Metered Dose to contain:
Ipratropium 20mca,
Levosalbutamol 50mcg
Cipla Limited
0.45 Perdose
5.88 Per2ml Amp
SALIPRAIR L 20 HFA
INHALATIONSAME AS IN ITEM
Rupees Nil AND Paise Four Five Only
Ruryes Nil AND Paise Four Five Only
L524 Budesonide Respule-
Each 2ml to contain :
Budesonide 1mg Steriod Nebulizing Fluid
2ml Amp
Cipla Limited FIRST BUDECORT lMGSAME AS IN ITEM
Rupees Five AND Paise Eight Eight Only4
Page 15 of 50
Prefercnce De*ription of stores accepfud
Equal to or more than 120 N4DI
Midas CarePharmaceuticalsArt. Ltd.
0.45 Per 200 MDI FIRST DUOLIN CFC FREE INHdose (WITH DOSE COUNTER)
SAME AS IN ITEM
24O MDI FIRST
2mlRespule
l"Y
ftem No Drug Description Packing
Firm Rate/unit Packing
Preference Description of stores acepted
Tlotropium Bromide Rotacap-
Each Rotacap to contain : llotropium Bromide IP/BP
Eqv. to Tiotropium Bromide Monohydrate 18mcg.
l Rotacap
Cipla Limited 30 CapsBottle
Rupees One AND Pai* Two Nine Only
1.29 Per1 Rotacap
4.03 Perl Tab/Cap
FIRST TIOVA ROTACAPS
SAME AS IN ITEM
IVAMAC 5SAME AS IN ITEM
10 Tabs FIRST
Zydus HealthcareLtd
MacleodsPharmaceuticalsLimited
SerdiaPharmaceuticals(India) PrivateLimited
1.39 Per 15 Caps SECOND TIOMIST RESPICAPS1 Rotacap Bottle SAME AS IN ITEM
2,27 Per 15 Caps THIRD AEROTROP1 Rotacap Bottle (HARD GELAIN CAPSULE)
SAME AS IN ITEM
Rupees Two AND Paise Two Seven Only
1530 l Tab/Cap
Rupees Four AND Paise Zero Thrce Only
Page 16 of 50
Employees' State Insura nce Corporation
Rate Schedule of Running Rate Contract No. U-25/121142C-L46C|2OL9-Med V FOR RC 143C
Valid from Thursday, october 14th 2021 to Tuesday, October 31't 2023
Firm Name
1525
MacleodsPharmaceuticalsLimited
Rupees One AND Paise fhrce Nine Only
Ivabradine Tab/Cap-Each Tab/Cap to contain: Ivabradine 5mg
15.00 Per 14 tabs SECOND CORAI-AN sMGl Tab/Cap Manufactured by:-
Les Laboratoires ServierIndustrie, FranceSAME AS tN ITEM
Ru@es Fifteen Only
t:
Employes' State fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-251121142C-L46C|zOL9-Med V FOR RC 143C
Valid from Thursday, October L4rb 2O2l to Tuesday, October 31i 2023
ftem No Drug Description Packing
Firm Name Firm Rate/unit Packing
Prefercnce
1668 Olmesartan Tab/Cap-
Each Tab/Cap to contain : Olmesartan 20mg
Sml InJ. FIRST
Zydus HealthcareLtd
13125.00 Per5ml
1.33 Per 10 Tabs SECOND OIMY 20l Tab/Cap SAMEAS IN ITEM
Rupees One AND Pai* Thrce Three Only
3.00 Per 15 Tabs THIRD OTMESAR 20I Tab/Cap SAME AS IN ITEM
OLIPIL 20SAME AS IN ITEM
FLOSEAT sMLManufactured By:-Baxter HealthcareCorporation, 21026Alexander court HaywardCalifornia US 94545SAME AS IN ITEM
Rupees Thte Only
t670 Haemostatic-
Each 5ml to contain:Haemostatic Matrix With Prefilled Gelatin Granules
In Syringes
5ml
PaBe 17 of 50
De*ription of stores ac@pted
1 Tab/Cap
Psychotropics India 0.82 PerLimited l Tab/Cap
MacleodsPharmaceuticalsLimited
Baxter (India) PvtLtd
10 Tabs FIRST
Rupees l{il AND Paise Eight Two Only
Ruwes Thifteen Thoumnd One Hundrcd Twenty Five OnlP
7^*t:
Employees' Sbte Insuran@ Corporation
Rate Schedule of Running Rate Contract No, U-25/12l142C-1,46C12OL9-Med V FOR RC 143C
Valid from Thursday, October L4th 2021. to Tuesday, October 31st 2023
ftem No Drug Description Packing
Firm Rate/unit Packing
t674 Sumatriptan Tab/Cap-
Each Tab/Cap to contain: Sumatriptan 50mg
1 Tab/Cap
10 Tabs FIRST SAME AS IN ITEM
Rupees Thirty Three Only
1681 Citicoline Tab/Cap-
Each Tab/Cap to contain: Citicoline 500 mg
1 Tab/Cap
PulsePharmaceutical hrtttd
Bajaj HealthcareLimited
33.00 PerI Tab/Cap
9.12 Perl Tab/Cap
10 Tabs FIRST COLIBRA
SAME AS IN ITEM
Rupees Nine AND Paise One Two Only
LO,77 Per 10 Tabs SECOND SAME AS IN ITEMl Tab/Cap
Rupees Ten AND Paise Seven Seven Only
USV Private Limited 2O.O0 Per 10 Tabs THIRD CITINERVEl Tab/Cap SAME AS IN ITEM
Rupees Twenty OrtfA
Page 18 of 50
Firm NameI Ptefetence
I
Oexriefion of sbrcs acepEd
Sun PharmaLaboratoriesLimited
4r-^-,r-,r r'-/.
Employes' StaE Insurance Corporation
Rate Schedule of Running Rate Contract No.U-25lLzlL42C-l46Clz0lg-Med v FOR RC 143C
Valid from Thursday, October L4rh aOZL to Tuesday, October 3L* 2023
PackingDrug Description
FirmPacking
Preference Description of sfurcs acepted
1682 Divalproex Sod. Tab/Cap-
Each SR/ER/CR Tab/Cap to contain:
Divalproex Sod. 250m9
PulsePharmaceutical PvtLtd
l0 Tabs FIRST DIOVAT XR 250SAME AS IN ITEM
10 Tabs FIRST DIOVATXR 5OO
SAME AS IN ITEM
Rupees Six AND Paise Nine Zero Only
IntasPharmaceuticalsLtd
PulsePharmaceutical hrtLtd
2.53 Perl Tab/Cap
Rupees One A^lD Pai* Eight Zero Only
4.48 Per lOTabs THIRD DIVAA-OD 250l Tab/Cap SAME AS IN ITEM
Rupees Four AND Paise Four Eight Only
1683 Divalproex Sod. Tab/Cap-
Each SR/ER/CR Tab/Cap to contain:
Divalproex Sod. 500m9
1 Tab/Cap
IntasPharmaceuticalsttd
/-^:
Page 19 of 50
ftem No
Firm Name Firm Rate/unit
1 Tab/Cap
1,71 Per1 Tab/Cap
Zydus HealthcareLtd
Rupees One AND Pai* Seven One Only
1.80 Per 10 Tabs SECOND DMTPRO XR 250l Tab/Cap SAME AS IN ITEM
Rupees Two AND Paise Five Thre Only
6.90 Per 10 Tabs SECOND DMA-OD 5OO
I Tab/Cap SAME AS It{ ITEM
Employees' State fnsura nce Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C'L46C|2OLg-Med V FOR RC l43C
Valid from Thursday, October L4th 2O2l to Tuesday, October 31st 2023
Packingftem No Drug Description
Firm Rate/unit Packing
Preference
t749 Equal to or more than 120 MDI
Rupees Nil AND Paise Two Seven Only
Cipla Limited 2OO MDI SECOND LEVOTIN CFC FREE INH(Wml DosE couNTER)
SAME AS IN ITEM
Rupees Nil AND Paise Three Thrce Only
Nebivolol Tab/Cap-
Each Tab/Cap to contain: Nebivolol Smg
1 Tab/Cap
10 Tabs FIRSTMacleodsPharmaceuticalsLimited
GennovaBiopharmaceuticalsLtd.
1,80 Perl Tab/Cap
22990.00 Per l Viall Vial
240 MDI FIRST
FIRST ELAXIM /+O
SAME AS IN ITEM
Pe0.33dose
r
t752 1 Vial
Page 20 of 50
Firm Ndme De*ription of storcs acephd
Inhaler-
Each Metered Dose to contain:
Levosalbutamol Tartrate 50mcg
175t
Midas CarePharmaceuticalsPvt. Ltd.
O.27 Perdose
BONAIR L HFA INHALATIONSAME AS IN ITEM
NEBIMAC 5 MG
SAME AS IN ITEM
Rupees One AND Paise Eight Ze,o Only
Tenecteplase 40mg Inj-Each Vial to contain: Tenecteplase 40mg
Rupees TwentyTwo Thouand Nine Hundrcd Ninev Only
4"-,r*/_
Employes' Sbte fnsuran@ Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-L46Cl2Ol9-Med v FOR RC 143C
Valid from Thursday, October L4th 2O2L to Tuesday, October 31"t 2023
PackingDrug Description
Firm Name Firm Rate/unit Packing
Preference Description of stores accepted
1754 Indapamide SR + Amlodipine Tab/Cap-
Each Tab/Cap to contain:
Tab/Cap Indapamide SR 1.5 mg,
Amlodipine Besylate Equivalent To Amlodipine 5 mg
1 Tab/Cap
SerdiaPharmaceuticals(India) PrivateLimited
Midas CarePharmaceuticalsPvt. Ltd.
Cipla Limited
Cipla Limited
10 Tabs FIRST NATRILAM 5SAME AS IN ITEM
Rupees Seven AND Paise Seven Nine Only
0.53 Per 240 MDI FIRST FLUSAL 250 HFA INHALATION
dose SAME AS IN ITEM
Rupees Nil AND Paise Six Three Only
0.86 Perdose
3.25 Perdose
120 MDI SECOND SEROFTO 250 CFC FREE INHSAME AS TN ITEM
2OO MDI FIRST SEROFTO 250 AUTOHALER
SAME AS IN ITEM
Rupees Three AND Paise Two Fi Onlyve
1840 Inhaler-
Each Delivered Dose to contain:
Salmetrol Xinafoate IP Equivalent to Salmetrol IP25 pg, Fluticasone Propionate IP 250p9, Excipients
& Propellant 1, 1,1,2 Tetrafluoro Ethane HFA 134a
Equal to or more than 120 MDI
with/ without spacer
1843 Autohaler-Each Delivered Dose Of Autohaler to contain:
Salmeterol (As Salmeterol Xinafoate) IP 25 mcg,
Fluticasone Propionate IP 250mcg Suspended In
Propellant 134a Q.S. (Contalns Absolute Alcohol Ip
5o/o v lv)
Equal to or more than 120 MDI
Page 21 of 50
ftem No
7.79 Perl Tab/Cap
Rupees Nil AND Paise Eight Six Only
l'^:
Employees' State fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-251121142C-L46C|2OL9-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31"t 2023
ftem No Drug Description Packing
Firm Name Firm Rate/unit Packing
Preference Description of stores accepfud
1845 Metoprolol Succinate SR Tab/Cap-
Each SR Tab/Cap to contain:
I4etoprolol Succinate 23.75m9 Equivalent To
It4etoprolol Tartrate 25mg
1 Tab/Cap
PulsePharmaceutical hrtLtd
Cipla Limited
MacteodsPharmaceutacalsLimited
MesmerPharmaceuticals
O.47 Perl Tab/Cap
0,52 Perl Tab/Cap
15 Caps
.10rabs FIRsr l_"tl9gE!-2!_: . ^_-(uNCoATED PROLONGED
RELEASE TABLEI)
SAME AS IN TTEM
Rupees Nil AND Paise Four Seven Only
Rupees Nil AND Paise Five Two2.7O Per 10 Tabs THIRDl Tab/Cap
METOLAR XR 25 CAP(HARD GELANN EXTENDED-
RELEASE CAPSULE)
SAME AS IN ITEM
OnlyMETOMAC 25(EffENDED -RELEASE TABLEI)SAME AS IN ITEM
E50MGSAME AS IN ITEM
Rupees Two AND Paise Seven Zero Only
1.59 Per 10 Tabs FIl Tab/Cap
Rupees One AND Paise Six Nine Only-r-
1 Tab/Cap1869 Amisulpride Tab/Cap-
Each Tab/Cap to contain: Amisulpride 50mg
Page 22 of 504,-/"'1il-t-
Employees' State Insu ra nce Corporation
Rate Schedule of Running Rate Contract No. U-25l12l142C-L46C|2OL9-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31st 2023
ftem No Drug Description Packing
Firm Name Firm Rate/unit Packing
Preference Description of stores accepfud
1870 Quetiapine Tab/Cap-
Each Tab/Cap to contain: Quetiapine 25 mg
l Tab/Cap
IntasPharmaceuticalsttd
IntasPharmaceuticalsLtd
0.94 Perl Tab/Cap
1.51 Perl Tab/Cap
12.91 Perl Tab/Cap
10 Tabs FIRST
10 Tabs FIRST
QUSER 25SAME AS IN ITEM
QUSER 100SAME AS IN ITEM
PEXEP-CR-25
SAME AS IN ITEM
Rupees Nil AND Paise lline Four Only
1.99 Per 10 Tabs SECOND QUTAN-2Sl Tab/cap SAME As IN ITEM
Rupes One AND Pai* Nine Nine Only
1 Tab/Cap
Rupees mre AllD Paise Nine Four Only
l Tab/Cap
Rupees Twelve AND Paise Nine One Onlyo
Page 23 of 50
MesmerPharmaceuticals
MesmerPharmaceuticals
IntasPharmaceuticalsLtd
loTabs FIRST
L87t Quetiapine Tab/Cap-
Each Tab/Cap to contain: Quetiapine 100 mg
Rupees One AND Paise Five One Only
3.94 Per 10 Tabs SECOND QUTAN-100l Tab/Cap SAME AS IN ITEM
1873 Paroxetine CR Tab/Cap-
Each CR Tab/Cap to contain: Paroxetine 25mg
/**:
Employees' State fnsurance Corporation
Rate Schedule of Running Rate Contract No, U-25/12l142C-L46C|zOLg-Med V FOR RC 143C
Valid from Thursday, October L4rh 2O2! to Tuesday, October 31't 2023
frcm No Drug Description Packing
Firm Name FirmPacking
Prefetence De$ription of stores acepted
Levetiracetam Tab/Cap-
Each Tab/Cap to contain: Levetiracetam 500m9
1 Tab/Cap
PulsePharmaceutical PvtLtd
2.42Perl Tab/Cap
HabPharmaceuticals &Research Ltd
Cipla Limited
Ruwes TWo AND Paise Four Two Only
2.90 Per 10 Tabs SECOND SAME AS IN ITEMl Tab/Cap
Rupees Two AND Paise Nine Zeru Only
2,92Per 15 Tabs THIRD LEVEPSY 5OO SAME AS INl Tab/Cap ITEM
Rupes TWo AND Paise Nine TWo Only
1880 Levetiracetam Tab/Cap-
Each Tab/Cap to contain: Levetiracetam 250mq
l Tab/Cap
Zydus Healthcarettd
1,49 Per
l Tab/Cap10 Tabs FIRST Epinext 250
SAME AS IN ITEM
Rupees One AND Pai* Four Nine Only
1.54 Per 15 Tabs SECOND LEVEPSY 250l Tab/Cap SAME AS IN ITEM
Rupees One AND Pai* Five Four Only
1.80 Per 60 Tabs THIRD LEVEI 500 MGl Tab/Cap SAME AS IN ITEM
Page 24 of 50
Firm Rate/unit
t879
IO Tabs FIRST EPINEXT 5OO
SAME AS IN ITEM
PulsePharmaceutical hrtttd
Cipla Limited
Rupees One AND Paise Eight Zero Only4)
/**
Employees' Sbte f nsu ra nce Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-t46ClzOL9-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31st 2023
ftem No Drug Description Packing
Firm Name Firm Rate/unit Packing
Preference Description of stores ac@pted
1883 Lamotrigine Tab/Cap-
Each Tab/Cap to contain: Lamotrigine 100m9
Rupees Six AND Paise One Eight Only
2014 1 Tab/Cap
IntasPharmaceuticalsLtd
Lark Laboratories(India) Ltd.
zydus Healthcar€Ltd
Cipla Limited
Midas CarePharmaceuticalsPl^. Ltd.
6.18 Perl Tab/Cap
1.08 Perl Tab/Cap
0.30 Perdose
0.34 Perdose
10 Tabs FIRST
10 Tabs FIRST MONTETAR-10SAME AS IN ITEM
Rupees One AND Pai* Ze,o Eight Only
1.98 Per lOTabs SECOND ODIMONT lOl Tab/Cap SAME AS IN ITEM
R One AND Paise Nine t
2OO MDI FIRST
24O MDI SECOND BESOT{E 2OO
SAME AS IN ITEM
Rupees Nil AND Paise Thrce Four Only-
2015 Beclomethasone Dipropionate IP 200mcg (HFA
Technology) Inhaler-
Each l\4etered Dose to contain:
Beclomethasone Dipropionate IP 200mcg(HFA Technology)
Page 25 of 50
l Tab/Gp
Montelukast Sodium Tab/Cap-
Each Tab/Cap to contain:
Montelukast Sodium 10mg
LAMEZ-1OO
SAME AS IN ITEM
BECLATE 2OO CFC FREE INHSAME AS IN TTEM
Rupees Nil AND Paise Three Zem Only
Equal to or more than 120 MDI
l^a
Employees' State fnsurance Corporation
Rate schedule of Running Rate contract No. u-25/12l142c-t46cl2oL9-Med v FoR Rc 143c
Valid from Thursday, October 1#h 2021 to Tuesday, October 31't 2023
Drug Description Packing
Firm Name Firm Rate/unit Packing
Prefercnce Description of s'tores ac@ptcd
2019 Indapamide (As SR)1.5m9 , Amlodipine Besilate
Equivalent to Amlodipine 2.5m9, Excepients QS Film
Coated Bi-Layered Tab/Cap-Each Film Coated Bi-Layered Tab/Cap Contains:
Indapamide (As SR)1.5m9 ,
Amlodipine Besilate Equvalent To Amlodipine2.5m9, Excepients QS
Rupees Seven AND Paise Four One Only
2022 l Tab/Cap
SerdiaPharmaceuticals(India) PrivateLimited
ZuventusHealthcare Limited
7.41Perl Tab/Cap
10 Tabs FIRST
lOTabs FIRST
NATRILAM 2.5SAME AS IN ITEM
Ruwes One AND Pai* Seven Seven Only
2.4OPer l0Tabs SECOND ARTIFLO2l TAb/Cap SAME AS IN ITEM
Rupees Two AND Paise Fourzeru Only
2060 Ambroxol + Terbutaline Tab/Cap-Each Uncoated Tab/Cap to contain:Hrdrochloride 30 mg, TerbutalineEquivalent to Terbutaline 2.5 mg
Ambroxol
Sulphate
1 Tab/Cap
2.31 Perl Tab/Cap
AMBROLITE ST
SAME AS IN ITEM
Rupees Two AND Paise Thrce One Only
Page 25 of 50
ftem No
1 Tab/Cap
Acenocoumarol / Nicoumalone Tab/Cap-
Each Tab/Cap to contain:Acenocoumarol / Nicoumalone 2mg
MacleodsPharmaceuticalsLimited
L.77 Petl Tab/Cap
ACENOMAC 2SAME AS IN ITEM
Tablets (India)Limited
10 Tabs FIRST
/"-*
Employees' State fnsu ra nce Corporation
Rate Schedule of Running Rate Contract No. U-25 | l2l t420-t46gl 20t9-Med V FOR RC 143C
Valid from Thursday, October l4th 2O2l to Tuesday, October 31st 2023
Item No Drug Description Packing
Firm Rate/unit Packing
Preference Description of stores ac@pted
Ambroxol + Terbutaline Syp-
Each 5 ml to contain: Ambroxol Hrdrochloride IP 30
m9, Terbutaline Sulphate IP Equivalent toTerbutaline 2.50 mg, Guaiphenesin IP 50 mg,Menthol IP 0.5 mq
100m1 Bottt
Rupees Twenty Nine AND Paise One Two Only
2063 Inhaler-
Each Inhaler to contain:
Fluticasone Propionate 250mca,
Formoterol Fumarate 6mcq
Equal to or more than 120 MDI
Midas CarePharmaceuticalsPvt. Ltd.
ZuventusHealthcare Limited
29.12 Per100m1 Bottt
0,73 Perdose
0,89 Perdose
6.80 Perl Tab/Cap
FIRST
240 MDI FIRST
AMBROLITE 25 1OOML
SAME AS IN ITEM
FTUTFOR 250 INHATATIONSAME AS IN ITEM
KIMETXL - 50SAME AS IN ITEM
Rupees Nil AND Paise Seven Thrce Only
120 MDI SECOND MAXIFLO 250 INH(WITH DOSE COUNTER)
SAME AS IN ITEM
Rupees Nil AND Paise Eight Nine Only
Rupees Six AND Paise Eight Zerc Only
SC)Metoprolol Tab/Cap-
Each Prolonged Release Film Coated Tab/Cap tocontain : S(-)Metoprolol Succinate 47.50 mg Eqv. toSC) Metoprolol Tartrate 50 mg
1 Tab/Cap
Page 27 ol 5O
L/
Firm Name
2061
Tablets (tndia)Limited
Cipla Limited
100m1
Boftle
10Tabs FIRST
2067
*T
Employees' State Insurance Corporation
Rate Schedule of Running Rate Contract No. U-25lL2l L42C-t46ClzOLg-Med V FOR RC 143C
Valid from Thursday, October L4th 2O2L to Tuesday, October 31't 2023
ftem No Drug Description Packing
FirmPacking
Prefercnce Dexription of stores accepfud
S(-)Metoprolol Tab/Cap-
Each CVPR/DR/SR/MR Tab/Cap to contain :
S(-)Metoprolol Succinate 23.75 mg Eqv. to S(-)Metoprolol Tartrate 25 mg
ZuventusHealthcare Limited
5.80 Perl Tab/Cap
10 Tabs FIRST KIMET XL - 25SAME AS IN ITEM
14 Tabs FIRST SAME AS IN ITEM
2069 licagrelor Tab/Cap-
Each Tab/Cap to contain:Tlcagrelor 90mg1 Tab/Cap
Ruryes Thirteen AND Paise Seven Seven Only
2070 Ivabradine Tab/Cap-
Each Film Coated Tab/Cap to contain: Ivabradine Hcl Equivalent To IvabradineT,5mg
1 Tab/Cap
Bajaj HealthcareLimited
SerdiaPharmaceuticals(India) PrivateLimited
SerdiaPharmaceuticals(India) PrivateLimited
L3.77 Perl Tab/Cap
17.86 Perl Tab/Cap
6.71 Perl Tab/Cap
Rupees Seventeen AND Paise Eight Six Only
Indapamide + Amlodipine Tab/Cap-
Each Film Coated Bilayered Tab/Cap to contain
Indapamide (As Sustained Release) 1.5m9 and
Amlodipine Besilate Equivalent to Amlodipine 10mg
l Tab/Cap
10 Tabs FIRST
Rupees Six AllD Paise Seven One Only
Page 28 of 50
a
Firm Name Firm Rate/unit
2068 1 Tab/Cap
14Tabs FIRST
Rupees Five AND Paise Eight Zero Only
CORALAN 7.sMGManufactured byi-Les Laboratoires SeruierIndustrie, FranceSAME AS IN ITEM
NATRILAM 10SAME AS IN ITEM
2074
f^^r
Employees' Sbte fnsurance Corporauon
Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OL9-Med V FOR RC 143C
Valid from Thursdan October 14th 2021 to Tuesday, October 31* 2023
ftem No Drug Desciption Packing
Firm Name Firm Rate/unit Packing
Preference Description of stores ac@pted
2076 f4icronised - Purified Flavonoid Tab/Cap-
Each Film Coated Tab/Cap to contain: Micronised -
Purified Flavonoid Fraction 1000m9-Composed OfDiosmin 900m9 (90olo) And Flavonoids Expressed As
Hesperidin 100mc ( 100/o)
1 Tab/Cap
Baxter (India) ArtLtd
14.29 PerI Tab/Cap
23094.00 Per1 PFS
SerdiaPharmaceuticals(India) PrivateLimited
10 Tabs
Rupees Fourteen AND Paise TWo Nine Only
10ml PFS FIRST FLOSEAL 1OML
Manufactured Byr-Baxter HealthcareCorporation, 21026Alexander court HaywardCalifornia US 94545SAME AS IN ITEM
Rupees Twenty Three Thousand Ninety Four Only
2078 Apixaban Tab/Cap-
Each Film Coated Tab/Cap to contain:Apixaban 2.5m9
1 Tab/Cap
FIRST DAFLON 1OOOMG
SAME AS IN ITEM
50.54 Perl Tab/Cap
10 Tabs FIRST ELTQUTS 2.sMGManufactured By:-M/s. Pfizer ManufacturingDeutschland GmbH,Betriebsstatte FreiburgMooswaldallee 1 NA Freiburg(Germany) -79090SAME AS IN ITEM
Rupees Fifty AND Paise Five Four Onlya
Hemostat-
Each PFS to contain:Hemostatic Matrix With
Syringe 10ml
Thrombin In Prifilled
1 PFS
Page 29 of 50
Pfizer Limited
2077
Employees' SEte fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25l12l142C-t46Clz0tg-Med V FOR RC 143C
Valid from Thursday, October l4th 2O2L to Tuesday, October 31st 2023
ftem No Drug Desciption Packing
Firm Name Firm Rate/unit
FirmPacking
Preference Dexription of storcs acepted
Apixaban Tab/Cap-
Each Film Coated Tab/Cap to contain:
Apixaban 5mg
Rupees Fifry TWo AND Paise Nine Five Only
2080 Dabigatran Tab/Cap-
Each Tab/Cap to contain:
Dabigatran Etexilate 110 mg
l Tab/Cap
BoehringerIngelheim IndiaPrivate Ltd
10.50 Perl Tab/Cap
50.00 Perl Tab/Cap
10 Tabs FIRST
Rupees Fifty Only
10 Caps FIRST SAME AS IN ITEM
Rupees Ten AM Paise Five Zero Only
10 Caps SECOND
ErrQUrs 5MGManufactured By:-M/s. Pfizer ManufacturingDeutschland GmbH,Betriebsstatte FreiburgMooswaldallee 1 NA Freiburg(Germany) -79090SAME AS rN rrEM,.
PRADAXA 150 MG
Manufactured by:-Boehringer IngelheimPharma GmbH & Co. KG,
Binger Str.173,55216,Ingelheim am Rhein,GermanySAME AS rN rTEU
Page 30 of 50
2079 l Tab/Cap
Pfizer Limited
PreciseChemipharma ArtLtd
52.95 Per
l Tab/Cap
{^^:
Employees' State fnsuran@ Corpration
Rate schedule of Running Rate contract No. u-2slL2lL42c-t46clzot9-Med v FoR Rc 143c
Valid from Thursdan October 14b 2O2l to Tuesday, October 31't 2023
Description ll4ckin9
Firm Name Firm Rate/unit Packing
Prefercnce De%ription of stores acepted
2081 4ml
WallacePharmaceuticalsPvt. Ltd.
13545.0O Per 4ml Kit4ml
TI$SEL LYOFibrjn Sealant VH ID powder and solventcontains
Component -1 contain sealer protein solutjon
a. 1 vial of human fibrinogen
b. 1 vial of synthetic aprotinin solutionC.omponent -2 hrombin solution containa. 1 vlal thrombin 500 IU (Lyophilized)
b. 1 vial of calcium chloride
Manufactured By:-Baxter AG, A-L22\ Vienna,Industriestrasse 67 Vienna -1221 Vienna (Austria)SAME AS IN ITEM
Rupees Thirteen Tltousand Five Hundrd Forty Fiye Only,
20.60 Per100 ml Bott
100m1Bottle
FIRST
Rupees Twenty AND Paise Six Zeru Only
2703 Terbutaline + Guiaphenesin + Ambroxol Syp-
Each 5 ml to contain:
Terbutaline I.P 1.25m9 + Guiaphenesin I.P 50mg +Ambroxol I.P 15mg Syrup Base QS
100 ml Bottle
Page 31 of 50
ftum No
Anticoagulants-
Each Kit to contain:Two Componant Fibrin Sealant With SyntheticAprotinin (4ml)
Baxter (India) PvtLtd
WALTUZ-BRSAME AS IN ITEM
FIRST
Employees' State Insura nce Corporation
Rate Schedule of Running Rate Contract No. U-25l12l142C-L46C|2OLg-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31't 2023
ftem No Drug Description Packing
Firm Name Firm Rate/unit Packing
Preference De*ription of storcs ac@pted
Dextromethorphan + CPM Syp-
Each 5 ml to contain: Dextromethorphan I.P 10mg
+ Chlorpheniramine lulaleate I.P 2mg Syrup Base QS
100m1 Bottle
Zenith Drugs hrt,Ltd.
WallacePharmaceuticalsPvt. Ltd.
Gopaldas VisramAnd CompanyLimited
18.43 Per
100m1 Bott
948.00 Per10ml
lOOmlBottle
10ml Vial FIRST
200MeteredDose
FIRST
FTBRICOR
SAME AS IN ITEM
GTN SPRAY
SAME AS IN ITEM
FIRST SAME AS IN ITEM
Rupees Eighteen AND Paise Four Three Only
19.70 Per 100m1 SECOND WALTUZ-DX100m1 Bott Bottle SAME AS IN ITEM
Rupees Nineteen AND Paise Seven ze,o Only
42.50 Per IOOmI THIRD SAME AS IN ITEM100m1 Bott Bottle
Rupees Forly Two AND Paise Five Zero Only
Ibutilide-Each ml to contain:
Ibutilide Fumarate 0.1m9 ( Equivalent To IbutilideFreebase 0.087mg), Water For Injection
10ml
2207 Glyceryl Trinitrate Spray-
Each Metered Dose to contain:
Glyceryl Trinitrate Spray -0.4 Mg
2OO MD
MedleyPharmaceuticalsLtd
Rupees Two Hundrcd Thirty Only
Page 32 of 50
2204
ZuventusHealthcare Limited
Rupees Nine Hundrcd FoW Eight Only
230.00 Per2OO MD
2205
f<
Em ployees' State fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25l12l142C-L46C|zOL9-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31"t 2023
ftem No Drug Description Packinq
Firm Rate/unit Packing
Preference De*ription of stotes accepEd
Human Albumin-
Each Bott to contain- Human Albumin 25olo 100 ml
In Flexible, Self Collapsible- Closed System Bags
Baxalta BioscienceIndia PrivateLimited
Roche Products(India) Pvt Ltd
4233.00 Per
100m1 Bott
81437.00 Per l Vial1 Vial
FLEXBUMIN
Manufactured by:-Baxalta US INC. USA
SAME AS IN ITEM
HEMLIBRA 30 MG
Manufactured by:-M/s. F. Hoffmann-La RocheLtd, Wurmisareg,CH- 4303/ Kaiseraugst,SwitzerlandSAME AS Iil ITEM
100m1
Bag
FIRST
Rupees Four Thousand Two Hundred Thifi Thrce Only.
40754,00 Per l Vial1 Vial
FIRST
Rupees Forty Thousand Seven Hundrcd Fifry Four Only
22t0 Emicizumab Inj-Each Vial Contains :
Emicizumab 60mg For Sub Cut Injection (R-DNA
Oriqin)
1 Vial
FIRST
2209 Emicizumab Inj-Each Vial Contains :
Emicizumab 30mg For Sub Cut Injection (R-DNA
Oricin)
1 Vial
Firm Name
2208 100m1 Bottle
HEMUBRA 60 MG
Manufactured by:-M/s. F. Hoffmann-La RocheLtd, Wurmisweg,CH- 4303, Kaiseraugst,SwitzerlandSAME AS IN TTEM
Roche Products(India) Pr^ Ltd
Rupees Eighty One Thousnd Four Hundrcd Thirty Seven Onllo
Page 33 of 50
Employees' Sbte fnsu ra nce Corporation
Rate Schedule of Running Rate Contract No. U-25lL2lL42C-l46Cl20!g-Med V FOR RC 143C
Valid from Thursday, October 14th 2O2L to Tuesday, October 31st 2023
Item No Drug Description Packing
Firm Rate/unit Packinc
Prefercnce
22t1 Micronized - Purified Flavonoid Tab/Cap-
Each Film Coated Tab/Cap to contain :
Micronized - Purified Flavonoid Fraction 500m9
Composed Of Diosmin 450m9 (90o/o) And
Flavonoids Expressed As Hesperidine 50mq (10olo)
1 Tab/Cap
10 Tabs FIRST DAFLON SOOMG
SAME AS IN ITEM
Rupees Eight AND Paise Eight Eight Only
2299 Telmisaftan Tab/Cap:
Each Tab/Cap to contain: Telmisartan 20mg
1 Tab/Cap
SerdiaPharmaceutacals(tndia) PrivateLimited
PreciseChemipharma hrtLtd
8.88 Perl Tab/Cap
50.00 Perl Tab/Cap
USV Private Limited 0.73 Perl Tab/Cap
10 Tabs FIRST TAZLOC 2OMG
SAME AS IN ITEM
Rupees Nil AND Paise Seven Thrce Only
1.14 Per 10 Tabs SECOND MACSART 20l Tab/Cap SAME AS IN ITEM
One AND Paise One Four
12.50 Perl Tab/Cap
10 Caps FIRST SAME AS IN ITEM
Rupees Tfuelve AND Paise Five Zem Only
10 Caps SECOND
Ruryes Fifty Only
PRADAXA 110 MG
Manufactured by:-Boehringer IngelheimPharma GmbH & Co. KG,
Binger Str.173,552L6,Ingelheim am Rhein,GermanySAME AS IN ITEM
?
Dabigatran Etexilate Tab/Cap-
Each Tab/Cap to contain:
Dabigatran Etexilate 150m9
1 Tablcap
Page 34 of 50
4
Firm Name De ription of stotes accepfud
BoehringerIngelheim IndiaPrivate Ltd
MacleodsPharmaceuticalsLimited
2302
f'y
ftem No Drug Description Packing
Firm Name Fim Rate/unit
FirmPacking
Description of stores ac@phd
Acetyl Salicylic Acid + Atorvastatin Tab/Cap-
Each Tab/Cap to contain:Acetyl Salicylic Acid 75m9, Atorvastatin 20mg
1 Tab/Cap
10 Caps FIRST
Rupees One AND Paise gix Nine Only
2306 Diltiazem CR/ SR/ DR/ MR Tab/Cap-
Each CR/ SR/ DR/ MR Tab/Cap to contain:
Diltiazem 90mg
1 Tab/Cap
Modi MundipharmaPrivate Limited
10 Tabs FIRST
100m1Bottle
FIRST
DILCONTIN XL 90SAME AS IN ITEM
WIROF SYRUP
SAME AS IN ITEM
Rupees One AND Pai*5even One Only
28.30 Per100m1 Bott
Rupees Twenty Eight AND Paise Th,ee Ze,o Only
29.60 Per 100ml THIRD CODICON COUGH SYP
100m1 Bott Bottle SAME AS IN ITEM
2309 Codein Lint, Syp/Susp-
Each 5ml to contain:
Chlorpheniramine Maleate 4mg,
Codeine Phosphate 10mq
100m1 Bottle
Page 35 of 50
Employees' Sbte fnsura nce Corporation
Rate Schedule of Running Rate Contract No. U-25l12l142C-t46Cl2OL9-Med V FOR RC 143C
Valid from ThuEday, October L4rh 2O2L to Tuesday, October 31st 2023
Prefercnce
2303
Cipla Limited ATORLIP ASP 20 CAP(GESTRO - RESISTANT TABLEI)SAME AS IN ITEM
1.69 Per
I Tab/Cap
1.71 Perl Tab/Cap
Windlas BiotechPrivate Limited
ConceptPharmaceuticalsLtd.
Rupees Twenty Nine AND Paise Six Zero OnlYo
fry
Item No Drug Description Packing
Firm Name Firm Rate/unit Packing
Preference
PulsePharmaceutical PvtLtd
2.7L Perl Tab/Cap
10 Tabs FIRST
BESONE 1OO INHALATIONSAME AS IN ITEM
Rupees Two AND Paise Seven One Only
l Tab/Cap
Cipla Limited 1.19 Perl Tab/Cap
10 Caps FIRST
Rupees One AND Paise One Nine Only
MesmerPharmaceuticals
Zim LaboratoriesLimited
Midas CarePharmaceuticalsPvt. Ltd.
Rupees One AND Paise Five Eight Only
1.73 Per 10 Caps THIRD EPINOZ-7sl Tab/Cap SAME AS IN ITEM
Ruryes One AND Paise Seyen Three Only
1040b Beclomethasone Inhaler-Each Metered Dose to contain:
Beclomethasone Dipropionate 100mcg.
Equal to or more than 120 MDI
O.42 Perdose
240 MDI FIRST
Rupees Nil AND Paise Four Two Only
Page 36 of 50
Employees' State f nsu ra nce Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|zOL9-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31't 2023
Description of sfurcs ac@phd
2312 Gabapentin + Nortriptyline Tab/Cap-
Each Tab/Cap to contain:
Gabapentin 100m9, Notriptyline 10mg
1 TAB/CAP
23t7 Pregabalin Tab/Cap-
Each PLAIN/SR/CR/DR/ER/MR Tab/Cap to contain:Pregabalin 75mg
DOLONEURON NT 1OO
SAME AS IN ITEM
NOVA 75SAME AS IN ITEM
1.58 Per 10 Tabs SECOND GABAWIN 75l Tab/Cap SAME AS IN ITEM
ta
Employees' State fnsu ra nce Corporation
Rate Schedule of Running Rate contract No. U-25l12l142C-!46ClzOLg-Med v FoR Rc 143C
Valid from Thursday, October 14th 2021 to Tuesdan October 31.t 2023
Firm NamePacking
De*ription of s,totes ac@PEd
Psychotropics IndiaLimited
Ru, Nil AND Paise Four Zerc
0.39 Perl Tab/Cap
MT tOC 50SAME AS IN TTEM
SECOND EMBETA.sOSAME AS IN TTEM
MONICORSAME AS IN ITEM
ASTHALIN ROTACAPS
SAME AS IN ITEM
Rupees Nil AND Paise Three Nine Only
IntasPharmaccuticalsLtd
1.51 Perl Tab/Cap
10 Tabs
10 TAbS FIRST
Rupees One AND Paise Five One OnlY
Paftem No
1043a
Metoprolol Tab/CaP-
Each Tab/CaP to contain :
Metoprolol Tartrate 50 mg
1056a
l Tab/CapIso-sorbide Mononitrate Ta
Each Tab/Cap to contain:
Iso-sorbide-5-Mononitrate 20 mg
blCap-1060a
Page 37 of 50
/*:
Firm Rate,/unit
Prefercnce
Salbutamol RotacaP-
Each Rotacap to contain : Salbutamol 200mca
1 Cap
Cipla Limited
14Tabs FIRST
0.40 PerI Cap
60 Caps
BottleFIRST
wallacePharmaceuticalsPvt. Ltd.
0.26 Perl Tab/Cap
Rupes Nil AIfiD Pai* ffuo Six OnlYa
,E* =+h rrr*, !c? dS 4F! ,.8 F[
-:: tJi*. g"-dtJc5
Druo
l Tab/Cap
Employees' StaE fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25l12l142C-t46Cl2OLg-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31't 2023
Drug Description Packing
Firm Name Firm Rate/unit Packing
Prefercnce Description of stores accepted
1 Tab/Cap
HindustanLaboratoriesLimited
IntasPharmaceuticalsLtd
3.51 Per 14 Tabs FIRST HIPRACINl Tab/Cap Strip SAME AS IN ITEM
Rupees Three AND Pai* Five One Only
5.33 Per 30 Tabs SECOT{D PRAZOPILT XL 2.5l Tab/Cap SAME AS IN ITEM
Rupees Five AND Paise Thrce Thte Only
6.60 Per 30 Tabs THIRD MINIPRESS XL 2.5MGl Tab/Cap Manufactured by:-
M/s, Pfizer Pharmaceuticals[LC,P.O Box No. 628,K 58.2RD 2,Barceloneta P R
00617,USASAME AS IN ITEM
Rupees Six AND Paise Six Zero Only
Prazosin SR Tab/Cap-
Each SR Tab/Cap to contain: Prazosin Hcl 5ms
l Tab/Cap
HindustanLaboratoriesLimited
Pfizer Limited
ftem No
1067b Prazosin SR Tab/Cap-
Each SR Tab/Cap to contain: Prazosin Hcl 2.5 mg
IntasPharmaceuticalsLtd
Pfizer Limited
7067c
4.85 Per 14Tabs FIRST HIPRACIN-Sl Tab/Cap SAME AS IN ITEM
Rupees Four AND Palx Eight Five Only
6,17 Per 30 Tabs SECOND PRA:ZOPLL XL 5l Tab/Cap SAME AS IN ITEM
Rupees Six AND Pal* One Seven Only
7.22Per 30 Tabs THIRD MINIPRESS XL sMGl Tab/Cap Manufactured by:-
M/s, Pfizer PharmaceuticalsLLC,P.O Box No. 628,K 58.2RD 2,Barceloneta P R
00617,USASAME AS IN ITEM
RupeesSeven AND Paise Two Two Onty ?
Page 38 of 50 4-.,r'"*
Employ@s' State fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2Ol9-Med V FOR RC 143C
Valid from Thurcday, October 14lj'2O2L to Tuesday, October 31't 2023
PackingDrug
Firm Name Firm RaE/unit
FirmPacking
Preference Dexription of sbrcs acePhd
1068b Ramipril Tab/ Cap-
Each Tab/ Cap to contain: Ramipril 2.5m9
l Tab/Cap
Cipla Limited
Sanofi IndiaLimited
Cipla Limited
MacleodsPharmaceuticalsLimited
Sanofi IndiaLimited
5.52 Perl Tab/Cap
0.48 Per 10 TAbS FIRST RAMIPRES 2.5
l Tab/Cap SAME AS IN ITEM
Rupees Nil AND Paise Four Eight Only
3.00 Per 1
l Tab/Cap
Rupees
0.1
E 2.5MGIN ITEMn
CARDACE sMG
SAME AS IN ITEM15 tabs
Rupees Five AND Paise Six Two Onll,
/od^-a-.r>-Ati-
Tal
blCiRamipril
Each Ta1068c
Page 39 of 50
ftem lUo
0.50 Perl Tab/Cap
10 TabS FIRST RAMIPRES 5
SAME AS IN ITEM
Rupees Three OnlY
l Tab/Cap
Rupees Nil AND Paise Five Zeto OnlY
10 Tabs SECOND MACPRIL 5SAME AS IN TTEM
Employees' State fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25l12l142C-l46Cl2OL9-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31st 2023
ftem No Drug Description Packing
Firm Rate/unit Packing
Prefercnce Description of stores accepted
1115b
Rupees Nil AND Paise Four Nine Only
Carbamazepin CR Tab/Cap-
Each CR Tab/Cap to contain: Carbamazepin 200m9
1 Tab/Cap
IntasPharmaceuticalsLtd
Sun PharmaLaboratoriesLimited
Cipla Limited
CentaurPharmaceuticalsPrrt. Ltd.
IntasPharmaceuticalsLtd
0.49 Perl Tab/Cap
1.11 Perl Tab/Cap
0,55 Perl Tab/Cap
10 Tabs FIRST
10 Tabs FIRST SAME AS IN ITEM
15 Tabs FIRST DYTOR 20SAME AS IN ITEM
Rupees One AND Paise One One Only
1370b Torsemide TabiCap-
Each Tab/Cap to contain: Torsemide 20mg
1 Tab/Cap
Rupees Nil AND Paise Six Five Only
2.29Per l0Tabs SECOND MELTOR 20MGl Tab/Cap SAME AS IN TTEM
Rupees Two AND Paise Two Nine Only
3.63 Per 15 Tabs THIRD TOR-2O
l Tab/Cap SAME AS IN ITEM
Rupees Thrce AND Paise Six Three Only,
PaBe 40 of 50
Firm Name
Phenobarbitone TabiCap-
Each Tab/Cap to contain: Phenobarbitone-30m9
l Tab/Cap
Ll27a
PHENOBARB 30SAME AS IN ITEM
t-
Employees' State fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/121142C-t46Cl20t9-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31st 2023
ftem No Drug Description Packing
Packing
1430b
Psychotropics IndiaLimited
1.12 Perl Tab/Cap
10 Tabs FIRST
15 Tabs FIRST
CTOBA-s TAB
SAME AS IN ITEM
Rupees One AND Paie One fwo Only
6,67 Per 10 Tabs SECOND SAME AS IN ITEMl Tab/Cap
RuBes Six AND Paise Six Seven Only
324a l Tab/Cap
Sun PharmaLaboratoriesLimited
IntasPharmaceuticalsLtd
IntasPharmaceuticalsLtd
2.27 Perl Tab/Cap
4,04 Perl Tab/Cap
Rupees TWo AND Paise Two Sevan Only
324b Clobazam Tab/Cap-
Each Tab/Cap to contain: Clobazam I.P.10 mg
1 Tab/Cap
Rupees Four AND Pai*Zerc Four Onllo
Page 41 of 50
Firm Name Firm Rate/unit
Prefercnce Description of storcs ac@pbd
Mirtazapine Tab/Cap-
Each Tab/Cap to contain: Mitazapine 15mg
1 Tab/Cap
MITRAPIT 15SAME AS II{ ITEM
Clobazam Tab/Cap-
Each Tab/Cap to contain: Clobazam 5 mg
15 Tabs FIRST
CTOBA-lo TAB
SAME AS IN ITEMz
Em ployees' State fnsurance Corporation
Rate Schedule of Running Rate Contract No.U-25lLzll42C-L46Cl2OL9-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31't 2023
ftem No Drug Description Packing
Firm Rate/unit Packing
Prefercnce
Salbutamol Resp. Soln-
Each ml to contain:
Salbutamol Sulphate Eqv. to Salbutamol 5 mg in
Normal Saline Soln.
Cipla Limited
Rupees Eight AND Paise Four Ze,o Only
336b Carvedilol Tab/Cap-
Each Tab/Cap to contain: Carvedilol 6.25m9
l Tab/Cap
Themis MedicareLimited
Bharat Serums AndVaccines Limited
0.214 Perl Tab/Cap
FIRST
10 Tabs FIRST
1 PFS FIRST
cvl 6.25SAME AS IN ITEM
LONOPIN 2OMG
SAME AS IN ITEM
Rupees Nil AND Paise Four Four Only
366a Enoxaprin Inj-Each PFS to contain:
Enoxaprin Sodium 20 mg / 0.2 ml.
1 PFS
Rupees One Hund,ed Forty Only
280.95 Per 1 PFS SECOND CLEHNE 20MGl PFS Manufactured by:-
M/s. Sanofi WinthropIndustrie, FranceSAME AS IN ITEM
Rupees Two Hundred Eighty AND Paise Nine Five Only
Firm Name Dexription of storcs acephd
32b 15 ml Bottle
8.4O Per15 ml Bott
140,00 Per1 PFS
15mlBottle
ASTHALIN RESPIRATOR SOL.
SAME AS IN ITEM
Sanofi IndiaLimited
{^ryPage 42 of 50
Employes' State fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-L46C|zOLg-Med v FOR RC l43C
Valid from Thursday, October 14th 2021 to Tuesday, October 31't 2023
Drug Description Packing
Firm Rate/unit Packing
Prefetence Description of storcs accephd
366c Enoxaparin 60 mg/0.6m1 Inj-Each PFS to contain: Enoxaparin 60 mg/0.6m1
1 PFS
1 PFS FIRST
Bharat Serums AndVaccines Limited
Midas CarePharmaceuticalsPr^. Ltd.
184.30 PerI PFS
200.00 Per l PFS
1 PFS
215.00 Per 1 PFS
1 PFS
0,65 Perdose
Rupees Two Hundrcd Only
VOXAPARIN 60SAME AS IN ITEM
SECOND TOMOH 60 MG
SAME AS IN ITEM
THIRD TONOPIN 6OMG
SAME AS IN ITEM
Rupees TWo Hundrcd Fifteen Only
Fluticasone + Salmeterol Inhaler-
Each Metered Dose to contain: Salmeterol 25mcg,
Fluticasone 50mcg
Equal to or more than 120 MDI
20 TabsBottle
FIRST
240 MDI FIRST
R Nil AND Paise Six Five On
FLUSAL 50 INHALATIONSAME AS IN ITEM
K-COR 5SAME AS IN ITEM
Rupees One AND Paise Six Zeru Onlyz
l Tab/Cap423a Nicorandil Tab/Cap-
Each Tab/Cap to contain: Nicorandil 5mg
Page 43 of 50
ftem No
Firm Name
Virchow BiotechA^. Ltd
EmcurePharmaceuticalsrtd
MacleodsPharmaceuticalsLimited
Rurees One Hundtd Eighty Four AND Pai* Thrce Zero Only
1.60 Perl Tab/Cap
420a
ftem No Drug Description Packing
Firm Name Firm Rate/unit Packing
Prefetence Dexription of storcs acephd
433b Sodium Valproate + Valproic Acid CR Tab/Cap-Each CR Tab/Cap to contain:(Sodium Valproate + Valproic Acid) Eqv. to Sodium
Valproate 500mq.
1 Tab/Cap
PulsePharmaceutical PvtLtd
1.78 Perl Tab/Cap
1O Tabs FIRST NEW VAT CR 5OO
SAME AS IN ITEM
Psychotropics IndiaLimited
1.79 Per 10 Tabs SECOND TAB VALATE CHRONO 500l Tab/Cap SAME AS IN ITEM
Sanofi - Synthelabo(India) PrivateLimited
Rupees One AND Paise Seven Nine Only
7,78PEr 10 Tabs THIRD VALPARIN CHRONO 5OO
l Tab/Cap SAME AS IN ITEM
Rupes Seven AND Paise Seven Eight Only
Propranolol Tab/Cap-
Each Tab/Cap. to contain: Propranolol 40mgl lab/Cap
SerdiaPharmaceuticals(India) PrivateLimited
1.32 Perl Tab/Cap
6.00 Perl Tab/Cap
10 Tabs FIRST
10 Tabs FIRST
Rupees Six Onl2
PROVANOL-40
SAME AS IN ITEM
COVERSYT 2MGSAME AS IN ITEM
R One AND Paise Thrce TWo
1 Tab/Cap
Page 44 of 50
Employees' State f nsu ra nce Corpration
Rate Schedule of Running Rate Contract No, U-25ll2ll42C-t46cl2OLg-Med V FOR RC 143C
Valid from Thursday, October L4th 2O2, to Tuesday, October 31st 2023
Rupees One AND Paise Seven Eight Only
44b
IntasPharmaceuticalsLtd
470a Perindopril Tab/Cap-
Each Tab/Cap to contain: Perindopril 2mg
Employees' Sbte fnsurance Corporation
Rate Schedule of Running Rate Contract No. U-25/12l142C-l46Cl2OLg-Med V FOR RC 143C
Valid from Thursday, October L4rh 2O2l to Tuesday, October 31* 2023
ftem No Drug Description Packing
Firm Name Firm Rate/unit Packing
Preference Description of stores acepfud
470c 1 Tab/Cap
10.06 Per 10 Tabs FIRST ZIMPRII.S
Rupees Ten AND Paise Zerc Six Only
SerdiaPharmaceuticals(India) PrivateLimited
MesmerPharmaceuticals
HabPharmaceuticals &Research Ltd
MesmerPharmaceuticals
l Tab/Cap
12.14 Perl Tab/Cap
1.51 Perl Tab/Cap
0.29 Per
l Tab/Cap10 Tabs FIRST
10 Tabs SECOND COVERSYL 8MGSAME AS IN ITEM
Rupees fwelve AND Paise One Four Only
bs FIRST RISAME AS IN ITEM
Rupees One AND Paise Five One Only
474b Olanzapine Tab/Cap-
Each Tab/Cap to contain: Olanzapine 5mg
l Tab/Cap
10 Ta
Rupees Nil AND Paise Two Nine Only
O.43 Per 10
OLANZAP.SSAME AS IN ITEM
SECOND OLZIC 5 MG
SAME AS IN ITEMTabs
l Tab/Cap
Rupees Nil AND Paise Four Thrce Only
473a Resperidone Tab/Cap-
Each Tab/Cap to contain: Resperidone 1mg
1 Tab/Cap
Page 45 of 50
Perindopril Tab/Cap-
Each Tab/Cap to contain: Perindopril Erbumine Bmg
Zim LaboratoriesLimited
P
Employes' State fnsuran@ Corporation
Rate Schedule of Running Rate Contract No.U-25lt2ll42o-l46cl2OL9-Med V FOR RC 143C
Valid from Thursday, October L4n' 2O2l to Tuesday, October 31st 2023
Packingftum No Drug Description
De*ription of s'torcs ac@phdFirm Rate/unit
FirmPacking
475b Haloperidol Tab/Cap-
Each Tab/Cap to contain: Haloperidol 5mg
1 Tab/Cap
10 Tabs FIRST SAME AS IN ITEM
Rupes One AND Pai* Four Four only
Amitripryline Tab/Cap-
Each Tab/Cap to contain: Amitriptyline 10mg
l Tab/Cap
10 Tabs FIRST
MicronPharmaceuticals
MesmerPharmaceuticals
MesmerPharmaceuticals
Zydus HealthcareLtd
IntasPharmaceuticalsttd
t.44 Perl Tab/Cap
0.52 Perl Tab/Cap
0.83 Perl Tab/Cap
10 Tabs FIRST
loTabs FIRST
AMICON 10 MG
SAME AS IN ITEM
AMICON 25 MG
SAME AS IN ITEM
XET 10SAME AS IN ITEM
Rupes llil AND Paise Five Two Onll
Amitriptyline Tab/Cap-
Each Tab/Cap to contain: Amitriptyline 25mg
l Tab/Cap
Rupees Nil AND Pai* Six One OnlY
486a l Tab/Cap
Rupees Seven AND Paise Eight Five Onlyn
Firm Name Ptefercnce
477a
0.61 Perl Tab/Cap
477b
Paroxetine Tab/Cap-
Each Tab/Cap to contain: Paroxetlne 10mg
Rupees Nil AND Paise Eight Thtee Only
7.85 Per 10 Tabs SECOND PEXEP-IO
l Tab/Cap SAME AS IN ITEM
l"-YPage 46 of 50
Packingftem No Drug Desciption
Firm Rate/unit Packinq
Prefetence Dexription of storcs acepted
486b Paroxetine Tab/Cap-
Each Tab/Cap to contain: Paroxetine 20mg
1 Tab/Cap
Zydus HealthcareLtd
PulsePharmaceutical PvtLtd
Cipla Limited
MacleodsPharmaceuticalsLimated
1.39 Perl Tab/Cap
0.57 Perl Tab/Cap
3,40 Perl Tab/Cap
Rupees One AND Paie Th,ee Nine Only
11.05 Per 10 Tabs SECOND PEXEP-2O
l Tab/Cap SAIIE AS IN ITEM
Eleven AND Paise Zero Five
10 Tabs FIRST XET 20SAME AS IN ITEM
loTabs FIRST
10 Tabs THIRD METOMAC 50SAME AS IN rTEMz
Ruryes Nil AND Paise FiYe Seven Only
0.65 Per 15 Caps. SECOND METOTARXR 50l Tab/Cap (HARD GELANN EXTENDED.
RELEASE CAPSULE)
SAME AS IN ITEM
Rupees Nil AND Paise Six Five Only
l Tab/CapMetoprolol ER Tab/Cap-
Each ER Tab/Cap to contain:
f4etoprolol Succinate 47.5m9Metoprolol Tartrate 50mq.
Equivalent to
525a
Page 47 of 50
Employees' State fnsurance Corpration
Rate Schedule of Running Rate Contract No. U-25/121142C-l46Clz0l9-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31"t 2023
Firm Name
IntasPharmaceuticalsLtd
METTOC ER 50SAME AS IN TTEM
Rupees fhree AND Paise Four Zeto Only
*
Employes' State fnsu ra nce Corporation
Rate schedule of Running Rate contract No. u-25l12l142c-t46cl2ol9-Med v FoR Rc 143c
Valid from Thursday, October 14th 2021 to Tuesday, October 31st 2023
Drug Packing
Firm Name Firm RaE/unit
FirmPackins
Prefercnce De*ription of stores ac@pted
527a Gabapentin Tab/Cap-
Each Tab/Cap to contain: Gabapentin 300mg1 Tab/Cap
SignaturePhytochemicalIndustries
Zim LaboratoriesLimited
MesmerPharmaceuticals
1.19 Perl Tab/Cap
1.74 Per 1O Capsl Tab/Cap
0.88 Perl Tab/Cap
SECOND GABAZIM 3OO
SAME AS IN ITEM
10 Caps FIRST SAME AS IN ITEM
Rupees One AND Paise One Nine Only
2.23Per 10Tabs THIRD PROGABA3OO MGI Tab/Cap SAME AS IN ITEM
Two AND Paise Two Three
l0 Tabs FIRST ZAPORIL 25 MGSAME AS IN ITEM
555a Clozapine Tab/Cap-
to contain: Clozapine 25mqEach Tab Ca
1 Tab/Cap
555b Clozapine Tab/Cap-Each Tqb/Cap to contain: Cloza pine 100m9
l Tab/Cap
Psychotropics IndiaLimited
MesmerPharmaceuticals
1.67 Perl Tab/Cap
10 Tabs FIRST PIIZEP 1OO
SAME AS IN TTEM
Rupees One AND Paie Slx Seven Only
1.87 Per 10 Tabs SECOND ZAPORIL lOO MGl Tab/cap SAME As IN ITEM
Rupees One AND Pai* Eight*ven Only
ftem No
MesmerPharmaceuticals
Rupees One AND Pai* Seven Four Only
Rupees Nil AND Paise Eight Eight Only
a
Page 48 of 50
'Jd.-'-t-.
Packingftem No Drug Description
Firm Rate/unit Packing
Prefercnce Dexription of stores ac@pted
556a Escitalopram Tab/Cap-
Each Tab/Cap to contain: Escitalopram 10 mg
I Tab/Cap
HabPharmaceuticals &Research Ltd
0.42 Perl Tab/Cap
10 Tabs FIRST
10 Tabs FIRST
PulsePharmaceutical PvtLtd
MesmerPharmaceuticals
Rupees Nil AND Paise Four Two Only
0.64 Per 10 Tabs SECOND LEXADEP 10l Tab/Cap SAME AS IN ITEM
Rupees Nil AND Pai* Six Four Only
0.79 Per 10Tabs THIRD ESCIPRA 10 MG
l Tab/CaP SAME AS IN ITEM
Ruryes Nil AllD Paise Seven Nine Only
ES-TDO(ASAME AS IN ITEM
ESCIPRA 20 MG
SAME AS IN ITEM
556b Escitalopram Tab/Cap-
Each Tab/Cap to contain: Escitalopram 20 mg
l Tab/Cap
Rupees One AND Pai* Two Four Only
Dalteparin Sodium Inj-Each PFS to contain:
Dalteparin Sodium 2500 IU Units
1 PFS
1 PFS FIRST
L.24Perl Tab/Cap
157.98 Per1 PFS
Rupees One Hund,ed Fifty Seven AND Paise Nine Eight Only
Page 49 of 50
Employees' State Insuran@ C.orporation
Rate Schedule of Running Rate Contract No. U-25/121142C-l46ClzOLg-Med V FOR RC 143C
Valid from Thursday, October 14th 2021 to Tuesday, October 31d 2023
Firm Name
FRAGMIN 25OO IUManufactured By:-M/s. Pfizer ManufacturingBelgium NV Rijksweg 12Puurs NA(Belgium), B-2870BelgiumSAME AS IN ITEM
..4?
MesmerPharmaceuticals
Pfizer PrcductIndia Private Ltd
557a
ft
Employes' SbE fnsurance CorPoration
Rate Schedule of Running Rate contract No. U-25/121142C't46Cl2OLg-Med V FOR RC 143C
Valid from Thurcday, October 14th 2021 to Tuesday, October 31"t 2023
ftem No
Description of stores accePbdPreferenceFirm Rate/unit
1 PFSDalteparin Sodium Inj-
Each PFS to contain:
Dalteparin Sodium 5000 IU Unlts
557b
Pfizer ProductIndia Private Ltd
Windlas BiotechPrivate Limited
Juggat Pharma(Pharma DivisionOf JagdaleIndustries PrivateLimited)
Bharat Serums And
Vaccines Limited
0.70 PerI Tab/Cap
4.65 Perl Tab/Cap
883.00 Per
l Vial
IOTAbS FIRST
10 Tabs
FRAGMIN SOOO IUManufactured BY:-
M/s. Pfi zer ManufacturingBelgium NV Riiksweg 12
Puurs NA(Belgium), B-2870
BelgiumSAME AS rN rrEM7.
FIXOHEAM.25OSAME AS IN ITEM
THROMBOFLUX 75OOOO I.U
SA]{E-.AS..II.{ ITEM
Rupees Nil AND Paise Seven Zero Only
SECOND BOTROSTATTABLETS
SAME AS IN ITEM a.
Rupees Four AND Paise Six Five OnlY
l Vial FIRST
Rupees Eight Hundrcd Eighty Three Only.
l Tab/CapEthamsylate Tab/CaP-
Each Tab/Cap to contain Ethamsylate 250 mg68a
Streptokinase Inj-
Each Vial to contain: Streptokinase I.P 7.5 Lac IU74a
Firm NamePa*inq
1 PFS FIRST260.23 Per
1 PFS
---
Rupees Two Hundrcd Sixty AND Paise TWo Thte Only
1 Vial
,
Page 50 of 50 lT